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Abstract
Brandon J. DeOre
THE ROLE OF SMALL GTPASES IN REGULATING BLOOD-BRAIN BARRIER
MECHANOTRANSDUCTION
2019-2022
Peter Galie, Ph.D.
Doctor of Philosophy
Fluid shear stress is an important mediator of vascular permeability, yet the molecular
mechanisms underlying the effect of shear on the blood-brain barrier (BBB) have yet to
be clarified in cerebral vasculature despite its importance for brain homeostasis.
Neurological symptoms including the formation of microclots, stroke, and other
neurological pathologies associated with changes in cerebral blood flow are hallmarks of
BBB dysfunction. The in vitro model used in this dissertation is compatible with realtime measurement of barrier function using a transendothelial electrical resistance as well
as immunocytochemistry and dextran permeability assays. These experiments reveal that
there is a threshold level of shear stress required for barrier formation and that the
composition of the extracellular matrix, specifically the presence of high molecular
weight hyaluronan, dictates the flow response. Gene editing to modulate the expression
of CD44, a mechanosensitive receptor for hyaluronan, demonstrates that the receptor is
required for the endothelial response to shear stress. Manipulation of small GTPase
activity reveals CD44 activates Rac1 while inhibiting RhoA activation. Additionally,
adducin-γ localizes to tight junctions in response to shear stress and RhoA inhibition and
is required to maintain the barrier. This dissertation identifies specific components of the
mechanosensing complex associated with the BBB response to fluid shear stress and,
therefore, illuminates potential targets for barrier manipulation in vivo.
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Chapter 1
Introduction
Approximately eight hundred thousand people in the U.S. suffer from strokes
annually, with ~87% being ischemic strokes that block blood flow to the brain [2]. An
ischemic stroke occurs when blood flow to a region of the brain is restricted, which leads
to local hypoxia and cell death. But the damage caused by cerebrovascular insult is not
due solely to a lack of oxygen: disruption of the blood-brain barrier (BBB) caused by
ischemia-reperfusion injury allows for plasma components to enter the surrounding tissue
and contribute to increased inflammation and cell death in the hours and days following
stroke. Both cerebral blood flow and the permeability of the blood-brain barrier undergo
well-defined oscillations during a stroke with the common trend that hypoperfusion
correlates with increased permeability[3]. For example, in the hours following
reperfusion, a “no- reflow” period exists that is characterized by both reduced cerebral
blood flow and blood-brain barrier breakdown [3]. These patterns suggest that the
mechanical stress exerted by blood flow regulates the integrity of the blood-brain barrier
through intracellular signaling pathways.
The blood-brain barrier is a highly specialized and restrictive barrier formed by
microvascular endothelial cells lining vasculature in the brain and spinal cord [4]. The
total surface area of the brain microvasculature, estimated to be between 12 – 20 m2
represents the primary barrier to material exchange between the blood and brain. The
BBB plays a crucial role in protecting the brain parenchyma from disruptive agents
including inflammatory factors, waste products, infectious microbes, and foreign
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molecules. The brain endothelium, comprised of brain microvascular endothelial cells
(BMVEC), is primarily responsible for the formation of a functional barrier [5, 6]. In
contrast to systemic vasculature, endothelial cells found within the CNS have distinct
phenotypic characteristics that enable their highly specialize function, including the
expression of tight junctions, reduced paracellularly transportation, lack of fenestrations,
and severely reduced pinocytic vesicles [4, 5, 7-9]. Furthermore, barrier integrity is
bolstered by the intimate association of the endothelial cells with adjacent pericytes,
astrocytes, microglial and neurons, forming a structure termed the neurovascular unit
(NVU) (Figure 1). Overall the BBB serves to maintain homeostasis in the brain
microenvironment and protects the CNS from physiological and pathological
conditions[4].

Figure 1. Representation of the Blood–Brain Barrier and Neurovascular Unit. Used with
permission from[10].
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Tight junctions (TJ), along with adherens junctions, make up the junctional complex of
the BBB. Specifically, TJs are located on the apical region of endothelial cells and
formed by a complex network of transmembrane and cytoplasmic proteins with
intertwined and parallel domains. This complex consists of membrane proteins, claudin,
occludin, and junction adhesion molecules (JAMS) supported by several scaffolding
proteins, primarily the Zonula-occludins (ZO-1, ZO-2, ZO-3) [11-13]. The scaffolding
proteins link the TJ to the actin cytoskeleton for structural integrity and maintenance of
function, giving rise to the highly restrictive physical properties of the BBB.
Claudins are dimers with 4 transmembrane domains that primarily bind to other
claudin molecules, physically interlocking adjacent endothelial cells [5, 6, 14]. Studies
investigating claudin knockdown in mouse models have shown that Claudin-5
knockdown leads to a terminally compromised BBB and non-viable phenotypes[4, 15,
16]. Other in vivo investigations have shown that Claudin-1 expression is decreased in
diseased sates induced by, MS, cancer, and strokes [15, 17-20]. In contrast, occludin has
been found to be non-essential for TJ function based on mouse knockout and knock down
studies [21, 22]. Previous work suggests that occludin assists in TJ regulation and
provides additional structural support via cytoplasmic binding domains [23, 24].
Zonula occludin proteins are submembrane TJ-associated proteins essential for BBB
function as they form the scaffolding link from the actin-cytoskeleton to the
transmembrane TJ complex [14, 25-28]. Without ZO-1, tight junctions cannot form as it
is the primary peripheral membrane protein that binds to TJ associated transmembrane
proteins including: claudins, occludins, and JAMS [Vorbrodt [5, 29, 30]]. Multiple
sclerosis models have shown that re-localization of ZO-1 from the periphery of the cells
3

to the cytosol directly results in increased permeability of the endothelium associated
with the pathology [31].
BBB disruption is observed in pathologies associated with neurological
dysfunction including stroke, traumatic brain injury, Parkinson’s, Alzheimer’s disease,
HIV, COVID-19, and brain cancer. This disruption or impairment is characterized by
changes affecting BBB integrity, paracellular permeability, transportation pathways and
disrupted homeostasis. In Alzheimer’s disease, the level of BBB dysfunction is correlated
to accelerated rates of neurodegeneration, suggesting an intact BBB plays an important
role in preserving neuronal activity and preventing amyloid plaque formation [32].
Similarly, studies of Parkinson’s disease and epilepsy have reported that transient
opening of the BBB is likely due to elevated proinflammatory cytokines being released.
Additionally, brain tumors are characterized by “leaky” capillary beds due to long term
elevations in growth factors like VEGF and inflammatory cytokines, which contribute to
chronic BBB disruption. Inflammatory cytokines associated with the tumor
microenvironment, including IL-1β and TNF- α, have also been reported to be
upregulated in animal models of ischemic stroke [Feurestein, Tarkowski]. In vitro studies
have shown BBB monolayers exposed to these cytokines experience loss of barrier
integrity[25, 33].
Cell-cell junctions of endothelial cells also undergo dynamic changes when
exposed to different biomechanical and biochemical stimuli. Several studies have shown
that endothelial cells are affected by fluid shear stress; they exhibit changes in
morphology [34, 35], gene expression [36, 37], and phenotypic function[38, 39]. Steady
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state shear stress has been shown to promote production of nitric oxide (NO), which has
been shown to be protective of the BBB during reperfusion injury observed after
restoration of flow following ischemic stroke [3, 18, 40, 41]. Furthermore, studies
looking at genetic response to shear stress have reported elevated mRNA expression of
proteins that comprise the tight junctions such as ZO1, Claudin-1, and Claudin-5 [38, 42].
Additionally, fluid shear stress has been reported to reduce barrier permeability in both
systemic and BBB-based vascular models [35, 39, 43-45]. Conversely reduced or altered
fluid shear levels or flow profiles results in altered BBB integrity. Recent studies have
shown that disturbed flow profiles like those observed in aneurism significantly reduce
barrier integrity and expression of TJ associated proteins [38, 46].
Although several mechanosensing mechanisms of fluid shear stress have
previously been identified in endothelial cells in systemic vasculature [47-51], including
pathways involving the glycocalyx [52], the PECAM-VEGFR2-VE-cadherin complex
[35], and Notch signaling [44], mechanotransduction within tight junction-forming
endothelial cells remain unclear. However, there is substantial evidence that the integrity
of the barrier is mediated by the composition of the surrounding extracellular matrix.
Previous studies have shown that elevated concentrations of low molecular weight
hyaluronic acid, less than 20 monosaccharide units in length (oHA) [53] disrupt barrier
function [54] and promote cytoskeleton remodeling [55] and angiogenic sprouting [56,
57]. Conversely, HMW-HA (greater than 1MDa) [53] has been shown to be antiangiogenic [57] and anti-inflammatory [58] and promote vascular barrier integrity [59].
These processes are mediated in part by the primary cell-surface receptor for HA, CD44,
which regulates the activity of small GTPases RhoA and Rac1 [55, 59, 60]. Previous
5

studies have demonstrated that increased RhoA activity leads to a disassembly of the
complexes within cell-cell junctions and subsequent barrier disruption [33, 49, 61].
Another small GTPase, Rac1, has been associated with stabilization of the BBB [62, 63],
and phosphorylation of adducin-g, an F-actin capping protein associated with tight
junctions [64]. Recent studies have also identified Rac1 activation as a downstream
response to fluid shear stress in systemic vasculature [44]. These previous findings
suggest that the CD44 receptor and small GTPases like RhoA and Rac1 potentially serve
as mechanosensitive regulators of BBB integrity.
Given recent findings that the SARS-CoV-2 spike protein disrupts barrier
integrity in the presence of fluid shear stress [65], this study also interrogates whether
there is crosstalk between the cell response to both stimuli. The spike protein of SARSCoV-2 is known to bind to ACE2 [66], which is present on the surface of endothelial
cells in the central nervous system [67]. Yet, the downstream effects of spike-ACE2
binding and the mechanisms underlying barrier breakdown in response to spike protein
remain unclear. Previous studies have suggested that the SARS-CoV-2 virus increases the
expression of ACE2 [68], providing a means for the virus to act as a “trojan horse” and
amplify infection. Similarly, the application of shear stress to vascular endothelial cells
showed a transient increase in ACE2 expression [69]. The connection between shear
stress, ACE2, and spike protein-mediated barrier disruption suggests a shared signaling
component that can elucidate our understanding of the mechanisms involved in BBB
regulation.
The central hypothesis of this dissertation is that small GTPases RhoA and Rac1
are key mediators of blood-brain barrier integrity in response to both biomechanical and
6

biochemical stimuli including fluid shear stress and the SARS-CoV-2 spike protein. The
following specific aims will evaluate this hypothesis:
1.1 Specific Aim 1: Interrogate the Effects of Fluid Shear Stress on Small-GTPaseMediated Barrier Regulation
This aim will interrogate the response of the BBB to varied levels of applied fluid shear
stress. A molecular basis for signal transduction will be evaluated by interrogate the role
of small GTPases in barrier formation and integrity in response to applied fluid shear
stress.
1.2 Specific Aim 2: Evaluate Rhoa Activity in Response to Sars-Cov-2 Spike Protein
and Fluid Shear Stress.
We will expose the BBB to the S1 subunit of SARS-CoV-2 spike protein in perfusion
culture. Vessels exposed to constant fluid shear stress will be challenged with the spike
protein allowing dynamic evaluation of barrier breakdown. In this aim we will rescue
barrier breakdown due to spike protein via GTPases inhibitors.
1.3 Specific Aim 3: Assess the Role of Small GTPase Activity on Cell Sheet Mechanics
Using Microindentation.
The final aim will examine the mechanics of cell sheets and determine the effects of
RhoA activation. Using a novel hemi-spherical cell sheet model, microindentation reveals
mechanics independently of any contributes from the ECM.
This proposal seeks to elucidate a novel mechanistic relationship between the effects of
fluid shear stress and SARS-CoV-2 on the integrity of the BBB. Successful completion
7

of the specific aims will yield three key innovations in the field of mechanobiology. The
first establishes mechanistic understanding of the role shear stress in BBB formation and
integrity. The second identifies a potential mechanism by which COVID-19 leads to
cerebral vascular dysfunction as well as a means to mitigate its effects. The third provides
mechanical understanding of the effects of altered RhoA activity on cell sheet mechanics.
Taken together the work proposed here explores novel mechanistic insight into the role of
RhoA in tight junction regulation.
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Chapter 2
CD44 Mediates Shear Stress Mechanotransduction in an In Vitro Blood-Brain
Barrier Model Though Small GTPases RhoA and Rac1 [43]
2.1 Introduction
Recent studies have established that the integrity of the blood-brain barrier (BBB)
is regulated by the mechanical stress exerted by blood flow; both fluid shear stress [38]
and cyclic strain [39] decrease the permeability of in vitro models of cerebral vasculature.
These findings mirror the results in systemic vasculature, yet blood vessels in the central
nervous system (CNS) are substantially different in both structure and function compared
to vasculature found elsewhere in the body. The primary difference is the formation of
endothelial tight junctions, complexes of claudins and occludin stabilized by scaffolding
proteins including zonula occludens-1 that give rise to the BBB [10]. Moreover, the
extracellular matrix (ECM) of the CNS is also drastically different than other organ
systems [70]. The CNS ECM features high concentrations of proteoglycans and
glycosaminoglycans, specifically high molecular weight hyaluronan (HMW-HA) [71],
and a lack of fibrillar collagens that are common elsewhere the body. The differences in
structure and function of vasculature and the surrounding extracellular matrix in the CNS
suggest the possibility of unique mechanotransduction mechanisms in the BBB.
Although several mechanosensing mechanisms of fluid shear stress have
previously been identified in endothelial cells in systemic vasculature [47-51], including
pathways involving the glycocalyx [52], the PECAM-VEGFR2-VE-cadherin complex
[35], and Notch signaling [44], mechanotransduction within tight junction-forming
9

endothelial cells remain unclear. However, there is substantial evidence that the integrity
of the barrier is mediated by the composition of the surrounding extracellular matrix.
Previous studies have shown that elevated concentrations of low molecular weight
hyaluronic acid, less than 20 monosaccharide units in length (oHA) [53] disrupt barrier
function [54] and promote cytoskeleton remodeling [55] and angiogenic sprouting [56,
57]. Conversely, HMW-HA (greater than 1MDa) [53] has been shown to be antiangiogenic [57] and anti-inflammatory [58] and promote vascular barrier integrity [59].
These processes are likely mediated in part by HA receptor CD44, which regulates the
activity of small GTPases RhoA and Rac1 [55, 59, 60]. Previous studies have
demonstrated that increased RhoA activity leads to a disassembly of the complexes
within cell-cell junctions and subsequent barrier disruption [33, 49, 61]. Another small
GTPase, Rac1, has been associated with stabilization of the BBB [62, 63], and recent
studies have also identified Rac1 activation as a downstream response to fluid shear
stress in systemic vasculature [44]. The connection between hyaluronan, small GTPase
signaling, and barrier integrity insinuates a potential role of CD44 as a mechanosensor in
the BBB.
However, studying BBB mechanotransduction in animal models is complicated
by multiple time and spatial-varying factors present in vivo. Therefore, the results
described here use a previously described three-dimensional model of the BBB [39].
Despite several differences compared to in vivo vasculature, including the lack of a
tortuous and branched morphology, absence of immune cells including microglia, and
use of culture medium for perfusion instead of blood, the in vitro model provides a
controlled setting to interrogate the molecular mechanisms underlying the response to
10

shear stress. Moreover, cells can be genetically or transcriptionally altered prior to
incorporation into the device to determine the effects of specific components of the
signaling pathway. The device is compatible with dextran-FITC permeability assays as
well as immunocytochemistry. A TEER device has also been developed for this
microfluidic system, allowing non-invasive measurements of barrier integrity. Taken
together, the device provides a robust platform to study BBB mechanotransduction.
2.2 Methods
2.2.1 Microfabrication
Polydimethylsiloxane (PDMS) microfluidic devices were manufactured as
described previously [39]. Briefly, positive master molds of the devices manufactured
using stereolithography (Protolabs, Maple Plain, MN) were used to cast negative and
positive PDMS master molds which were then used to fabricate the microfluidic device
for the 3D model. For monolayer flow experiments, 5-g of PDMS was added to a p100
culture dish and leveled prior to curing. The hydrogel reservoir was etched with 5M
sulfuric acid for 90 minutes, thoroughly washed with Millipore water, and subsequently
coated with 20 µg/mL collagen for 60 minutes. For monolayer plates, a 40-mm glass
cover slip was used to constrain the fluids on the dish. All steps were performed at room
temperature. Devices were sterilized under shortwave length ultraviolet light prior to cell
seeding.
2.2.2 Cell Culture
All cell experiments were performed with p21-24 hCMEC/D3 (gifted from Dr.
Robert Nagele’s lab at the Rowan School of Osteopathic Medicine, P21-P24 represents
11

passages since original immortalization in the laboratory of Prof. Pierre Olivier Couraud)
3-5 days after thawing and feeding with modified EGM-2 on 1% gelatin coated tissue
culture plates [72]. Normal human astrocytes (NHA) (Lonza, Walkersville, MD) were
thawed at P5 and cultured for 5-10 days prior to cell seeding. Cell cultures were
maintained at 37oC with 5% CO2 and 95% relative humidity.
2.2.3. In Vitro Blood-Brain Barrier Models
Three-dimensional models of the blood-brain barrier (3D BBB) were fabricated as
described previously [39]. Briefly, a hydrogel composed of 5 mg/mL type I collagen, 1
mg/mL HA (>1MDa), 1 mg/mL Matrigel [73] were used to fabricate the scaffold. When
incorporated into the hydrogel, NHA were seeded at 1 million cells per mL. The gel was
injected into the hydrogel reservoir of the device and 180-µm needles coated in 0.1%
BSA for one hour at room temperature or overnight at 4oC were inserted prior to
polymerization of the hydrogel. The needles were removed after the gel was polymerized
leaving two voids in the hydrogel in which hCMEC/D3 were injected into one channel at
a density of 10 million per mL (15 µL per channel). Channels were incubated for 10
minutes to ensure cell attachment then injected with cells again and inverted for 10
minutes to coat the upper hemisphere. Following cell seeding, channels were either
exposed to flow using a linear syringe pump (Kent Scientific, Torrington, CT) or
incubated in static conditions in a 6-well plate. For GTPase activity assays, a larger
diameter (1-mm) model was used [46] due to insufficient protein yields from the smaller
model. For both models, cell seeding is considered day 0 for experimental timelines. A
2D model was employed for pull-down and immunoprecipitation assays, the same
hydrogel formulation was polymerized on the treated PDMS coated plates under a sterile
12

40-mm glass coverslip to create a uniform circular hydrogel. Following removal of the
cover slip, hCMEC/D3 were seeded on the gel at a density of 4k/cm2 and allowed to
adhere for 30 minutes prior to addition of EGM-2. Monolayers were incubated for 4 days
in static culture to ensure confluency, then exposed to fluid shear stress. Fluid shear stress
was applied using a 40-mm 1-degree cone plate on a rheometer (Waters, Milford, MA)
for 24-hrs on a Peltier plate set to 37oC. The media was supplemented with HEPES buffer
to a final concentration of 10 mM to maintain pH and sterile Millipore water was added
to the plate during exposure of flow to counteract evaporative loss [74].
2.2.4. Immunocytochemistry
Following exposure to experimental conditions, vessels were fixed in 4%
paraformaldehyde (Alfa Aesar, Ward Hill, MA) for 30 min at room temperature.
Following fixation, the top layer of the device was removed with a razor blade and then
the hydrogel was removed from the device and placed in 0.1% Triton X-100 to
permeabilize the cell membrane. Gels were blocked in 5% normal donkey serum or 3%
BSA for 30 minutes at room temperature followed by incubating overnight with primary
antibodies for either HCAM (CD44) (Santa Cruz, Dallas, TX), glial fibrillary acidic
protein (GFAP), adducin-γ (add-γ) (Abcam, Cambridge, MA), or zonula occludin-1 (ZO1) (CST, Danvers, MA). Following primary incubation, gels were washed three times
with PBS for 5 minutes then incubated with the appropriate secondary antibody
conjugated to Alexa 555 (CST), Alexa 488 (Santa Cruz), or Dylight 650 (Thermo
Scientific, Waltham, MA). Gels were counter-stained with DAPI to label nuclei and
FITC-phalloidin for actin. All gels were imaged using a Nikon A-1 confocal scanning
microscope.
13

2.2.5 Permeability Testing
After exposure to experimental conditions, channels were transferred to the stage
of an inverted epifluorescent microscope enclosed by an environmental chamber set to
37C, 5% CO2, and 95% RH. The channels were perfused with 4-kDa dextran-FITC at a
flow rate of 5 µL/min using a syringe pump for 10 minutes, while submerged within
culture medium to ensure cell viability. This flow rate was selected to assure fully
developed flow throughout the channel and to maintain consistency with previous work
[39]. Images were taken at 30s intervals for 10 minutes, and the diffusion coefficients
were established using the following equation from previous work [75].
!" $

𝑃 = !# %&

(1)

!

Where P is the permeability constant, di/dt is the rate of change of fluorescence intensity
outside the vessels, r is the radius, and Io is the intensity inside the vessel. Sample
numbers of n ≥ 3 were used to determine the mean and standard deviation of diffusion
coefficients for each condition.
2.2.6. Impedance Spectroscopy and Transendothelial Electrical Resistance (TEER)
Measurements
Impedance measurements were obtained by a stingray DS1M12 USB oscilloscope
adapter (USB Instruments, Cleveland, OH) that measured current across a reference
resistor for a range of frequencies. Impendence, defined as Z=V/I, was measured at 15Hz, where capacitance of the electrodes dominates, and 15.6-kHz, where resistance of the
culture media dominates [76]; the difference between these two values yielded the TEER
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magnitude. These values were normalized to the impedance of an acellular hydrogel
within the microfluidic device. Sample numbers of n ≥ 3 were used to determine the
mean and standard deviation of TEER measurements for each condition.
2.2.7. CD44 Knockdown
Commercially available CRISPR plasmids (Santa Cruz Biotechnology, Dallas,
TX) were used to alter the expression of CD44 within the hCMEC/D3 cells prior to
introduction into the 3D BBB model. To knockout CD44 in the cells, two plasmids
encoding a D10A mutated Cas9 nuclease and a CD44-specific 20 nucleotide guide RNA
were transfected into cells (sc-400209-NIC). The paired guide RNA sequences were
offset by approximately 20 base pairs to facilitate Cas9-mediated double nicking of
genomic DNA. For scrambled controls, a single plasmid encoding a non-specific guide
RNA sequence was transfected into cells (sc-418922). Briefly, cells were plated in a six
well plate and grown to 60-70% confluency. Cells were transfected with KO and control
plasmids resuspended in nuclease free water at 0.1 µg/µL. Both solutions were incubated
for 5 minutes at room temperature. Following incubation, solutions were mixed,
vortexed, and incubated for 20 minutes at room temperature. 300 µL of the plasmid
complex in 3 mL of culture medium was then added to each well. Media was replaced
after 48 hours with complete EGM-2 containing puromycin to select the cells. The
plasmids also contained a GFP cassette to assess transfection efficiency. Transfection
efficiency was also verified by western blotting: cells were lysed in sample buffer
containing DTT and LDS, boiled, and loaded onto a gel and separated with
electrophoresis. Proteins were transferred to a 0.45-µm PVDF membrane. Blots were
quantified by measuring band intensity using ImageJ and normalizing relative expression
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to control conditions. Membranes were incubated with anti-CD44 (1:50) or anti-Beta
actin (1:400) and visualized with HRP-conjugated secondary antibodies (1:4000). Sample
numbers of at least n ≥ 3 were used to determine the mean and standard deviation of
CD44 expression for each condition.
2.2.8 Adducin-γ Knockdown
DsiRNA directed against adducin-γ (add-γ) (IDT, Redwood City, CA) [77] was
used to knock down protein expression in hCMEC/D3 cells (Sense: GGA GCA GGA
CCA CAU CAU AAU CAC; Anti-sense: GAU GAU UAU GAU GUG GUC CUG CUC
CUU). Cells were plated in a 6-well plate at 250k per well. When cells reached 60-70%
confluency, DsiRNA was added using protocols adapted from IDBT. Briefly, DsiRNA
and negative control DsiRNA were resuspended in nuclease free water at 100 µM. The
stock solutions were diluted to 5 µM working solution consisting of 5x siRNA buffer and
nuclease free water. The working solution was diluted with transfection media to a
250nM concentration and incubated for 5 minutes at room temperature. Concurrently,
Dharmafect was mixed with transfection medium and incubated for 5 minutes at room
temperature. The solutions were mixed and incubated for 20 minutes prior to adding the
complex to complete EGM-2 to yield a final DsiRNA concentration of 25nM. 2 mL was
added per well of cells and incubated for 24 hours before replacing with complete EGM2. DsiRNA-mediated knockdown efficiency was verified using western blotting. Cells
cultured in a well plate for five days following plating were lysed for the western blots,
since this period matched the timing of permeability testing.
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2.2.9. RhoA Activation and Inactivation
In order to constitutively activate RhoA, vessels at day 4 were perfused with Rho
Activator II (Cytoskeleton) at a concentration of 2 µg/mL for four hours prior to use in
permeability tests or fixation for immunocytochemistry. To assess the effects of RhoA
inactivation, vessels were perfused with Rho Inhibitor I (C3 Transferase) (Cytoskeleton,
Denver, CO) at a concentration of 2 µg/mL for four hours prior to taking permeability
measurements at 20-min, 60-min, 120-min, and 240-min. Following 4 hours of static
conditions, vessels not used for permeability measurements were fixed for
immunocytochemistry.
2.2.10 ELISA-Based Quantification of Small GTPase Activity
Commercial ELISA kits were purchased from Cytoskeleton (G-LISA) to quantify
RhoA and Rac1 activation (Cytoskeleton). For both cases, cell lysates were prepared
using Cytoskeleton’s protocols. Following exposure to flow or static conditions, the
collagen/hyaluronan hydrogel was removed from the device and washed in ice cold 1x
PBS for 30 seconds. 50 µL of ice-cold cell lysis buffer with 1x protease inhibitor was
injected into vessels and collected in a microcentrifuge tube. The cell lysate solution was
spun at 10,000 g for 1 minute at 4oC to pellet cell debris. The supernatant was collected
and snap frozen in liquid nitrogen, reserving a small amount for protein quantification
using Precision Red (Cytoskeleton). Prior to measuring GTPase activity, samples were
thawed in a room temperature water bath and equilibrated to 0.5-1 mg/mL for RhoA and
0.5 mg/mL for Rac1 samples. Sample numbers of n ≥ 3 were used to determine the
mean and standard deviation of GTPase activation for each condition.
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2.2.11 Activated RhoA Pull-Down
Activated RhoA pulldown kits were purchased from Cytoskeleton. Sample lysates
were prepared similar to the protocol used for G-LISAs. Samples were processed using
Rhotekin-conjugated beads provided in the kit. 200 µg of protein was incubated with 15
µL of the beads, with 50 µg reserved for quantifying total RhoA present in the sample.
Following pulldown, samples were denatured in Lamelli buffer and separated using
electrophoresis. 10 µL of each sample was loaded per well on a 4-12% tris glycine gel in
MOPS buffer. The gel was transferred onto a 0.2-µm PVDF membrane. Following
transfer, the membrane was probed using the iBind flex kit and a primary anti-RhoA
antibody (Cytoskeleton) at 1:200 and HRP-conjugated secondary (1:4000). Blots were
quantified by measuring band intensity with ImageJ and normalizing relative expression
to control conditions. Sample numbers of n ≥ 3 were used to determine the mean and
standard deviation of permeability coefficients for each condition.
2.2.12 ZO-1 Immunoprecipitation
Immunoprecipitation of ZO-1 was performed using cell lysates extracted from
cell monolayers cultured on the collagen/HA hydrogels exposed to 24-hrs of fluid shear
stress applied by a cone and plate rheometer. The gels were removed from the rheometer
and washed immediately in ice cold PBS. The gels were then submerged in ice cold lysis
buffer (CST) and sonicated. Gels were then spun down at 14,000 g for 10 minutes at 4oC.
Supernatants were removed and snap frozen reserving a small aliquot for protein
quantification. Samples were equilibrated at 0.5 mg/mL protein concentration using ice
cold lysis buffer after thawing in a room temperature water bath. Samples were then
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loaded on a tris-acetate gel and separated using electrophoresis in tris-acetate buffer.
Protein was transferred to a 0.45-µm PVDF membrane. The membrane was incubated
overnight with ZO-1 (CST) (1:2000), add-γ (Abcam) (1:400), or Spectrin-αII (ABcam)
(1:1000) antibodies and visualized with HRP-conjugated secondary antibodies (1:4000).
Sample numbers of at least n ≥ 3 were used to determine the mean and standard
deviation of isolated protein for each condition.
2.2.13 Quantitative Reverse Transcription Polymerase Chain Reaction
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used
to measure the difference in message levels of CD44. mRNA was isolated from
hydrogels using the RNEasy spin columns (Thermo Scientific) and quantified using a
Nanodrop spectrophotometer. qScript reagent was used to reverse transcribe the isolated
mRNA, and PCR was conducted with SYBR Green. Message levels were double
normalized to Non-POU domain-containing octamer-binding protein (NONO) and the
control condition (flow or untreated with RhoA activator). Relative expression was
quantified as 2-ΔΔCT where CT is cycles to threshold. The forward and reverse sequences
for NONO are GTGTAGCGTCGCCGTTACTC and CCTTCATTTTGGCTGCTGGC
respectively, and for CD44 are GAAGAAAGCCAGTGCGTCTC
GTGCTCTGCTGAGGCTGTAA. Samples were measured in triplicate.
2.2.14. Proliferation Assay
Proliferation of CRISPR transformed cells was measured by studying the uptake
of thymine analogue Bromodeoxyuridine (BrdU) (Alfa Aesar, Ward Hill, MA) for 12 h
during exponential growth phase. Following fixation in 4% PFA Cells and permeabilized
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in 0.1% triton x100. DNA hydrolysis was performed by treating the cells with 1N HCL
(Fisher scientific, Waltham, MA) for 15 minutes at 37C. HCL was neutralized by
incubating cells in 0.1M Sodium borate buffer (ThermoFisher, Waltham, MA) for 10 min
at RT. Cells were then washed thoroughly with PBS then incubated overnight at 4 C with
1:50 PE-labeled anti-BrdU (Biolegend, San Diego, CA) and 1% BSA in PBST. Gels were
then counter stained with Hoechst 33324(1 µg/ml) (ThermoFisher, Waltham, MA) for 45
min at 37 C. ImageJ was used to calculate the number of dead cells and total cells in three
different regions per plate (n=3 plates per condition)
2.2.15 Viability Assay
Viability of CRISPR transformed cells was using cell impermeable nuclear stain
propidium iodide (2µg/ml) (ThermoFisher, Waltham, MA) to identify dead cells and
counter stained with cell-permeant nuclear stain Hoechst 33324(1 µg/ml) (ThermoFisher,
Waltham, MA). Cells were grown to 60-80% confluency in EGM-2 then incubated for 45
min in PBS containing the staining medium prior to imaging. ImageJ was used to
calculate the number of dead cells and total cells in three different regions per plate (n=3
plates per condition)
2.2.16. Statistical Analysis
The open-source statistics package, R, was used to perform all statistical
calculations. Data sets were tested for normality with Shapiro-Wilk tests prior to testing
for significance. One and two-way ANOVA tests followed by Tukey HSD post-hoc
comparisons were used to evaluate significant differences between multiple conditions.
Paired t-tests were used to compare fold change of Adducin/ZO1 and Spectrin/ZO1 with
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shear stress in the immunoprecipitation experiments. All other two sample comparisons
were made using Student’s t-tests. Each statistical test used sample numbers greater than
or equal to 3 unless otherwise noted and p < 0.05 was considered significant. All error
bars indicate standard deviation of the mean.
2.3 Results
2.3.1 A Threshold of Shear Stress is Required For Barrier Function
In order to gain a more complete understanding of the effect of shear stress on
barrier function, a range of shear stress levels was applied to the 3D BBB model for a
period of four days. Four different levels of shear stress (static control, 0.18, 0.35, 0.7,
and 2.1 dyn/cm2) were exerted by altering the volumetric flow rate of culture medium
perfusing through the 3D vessels, which are depicted in Figure 2 Ai-iii. This range of
shear stress was chosen to represent the lower end of the shear stress range present in the
brain vasculature [78], which previous measurements have shown is substantially
heterogeneous [79, 80]. Each vessel was submerged in culture medium during these
experiments to assure equal access to nutrients and oxygen regardless of perfusion rate.
Three separate assays evaluated barrier integrity: immunocytochemistry, FITC-dextran
permeability assays, and transendothelial electrical resistance (TEER) measurements. The
former two assays were conducted at the end of the perfusion period, but TEER
measurements could be performed daily without disrupting the vessels. Figures 1B-F
show the effect of varying magnitudes of fluid shear stress on the morphology of the
endothelial cells lining the in vitro vessel and localization of ZO-1, a tight-junction
associated scaffolding protein [81]. Figure 3 shows that tight junction formation in the
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0.7 dyn/cm2 condition also exhibits localization of claudin-5 and vascular-endothelial
cadherin to cell-cell junctions, validating the use of ZO-1 to assess barrier integrity with
immunocytochemistry. After 4 days in culture, static vessels (Fig. 2B) exhibited a
substantial amount of perinuclear ZO-1 staining, with irregular localization to the
junctions. Vessels exposed to low levels of shear stress (0.18 and 0.35 dyne/cm2 ) had a
similar response, as evidenced in Figures 2C and 2D, respectively. In contrast, the vessels
exposed to 0.7 and 2.1 dyn/cm2, indicated increased localization of ZO-1 to the cell-cell
junctions (Fig. 2E, F). There also appeared to be greater elongation of the cells in vessels
exposed to 2.1 dyn/cm2.
The TEER measurements validated the presence of a shear stress threshold,
exhibiting a significant increase in barrier integrity in vessels exposed to 0.7 and 2.1
dyn/cm2 at days 3 and 4 following seeding of the cells within the hydrogel (Fig. 2G), with
the 2.1 dyn/cm2 condition exhibiting significantly increased barrier at day 2. The
permeability measurements also found that vessels exposed to 0.7 and 2.1 dyn/cm2 shear
stress resulted in a significantly lower permeability compared to the static control at day 4
(Fig. 2 H). Although our previous studies indicated that the presence of astrocytes in the
outer hydrogel was not required for barrier function in response to shear stress [39],
TEER and permeability assays were conducted in astrocyte-seeded hydrogels at a subthreshold level of shear stress (0.18 dyn/cm2) to determine if glial cells could alter the
level of shear stress required for barrier formation. Figure 4 A-B indicates no significant
difference in FITC-dextran permeability and TEER values in hydrogels containing
astrocytes after exposure to 0.18 dyn/cm2. These findings further emphasize the
importance of fluid shear stress in barrier regulation in cerebral vasculature.
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image of hCMEC/D3-seeded channels cultured for 4 days in 3D (i), cross-section (ii),
and maximum projection in the x and y plane(iii) scale=100µm. B Static, C 0.18
dyn/cm2, D 0.35 dyn/cm2, E 0.7 dyn/cm2, F 2.1 dyn/cm2 images showing DAPI (blue),
phalloidin (green), and ZO-1 (red) (isolated in ii) staining of the vessel wall. scale=50
µm. G TEER measurements for channels exposed to static or shear conditions for 4 days,
*denotes p < 0.05 compared to Day 1 value for the static condition. H Permeability
coefficient of channels exposed to static, or shear conditions for 4 days measured with
4kDa dextran, *denotes p < 0.05 compared to static condition.
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Figure 3. Localization of Tight Junction and Adherens Junction Markers in Response to
Flow. A Fluorescent image of a vessel stained with DAPI (blue), phalloidin(green), and
claudin-5(red) (isolated in ii) B Fluorescent image of a vessel stained with DAPI (blue),
phalloidin(green), and VE-Cadherin (magenta) (isolated in ii). Scale: 25µm
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perfused for 4 days. B TEER measurement for channels seeded with hCMEC/d3 cultured
with and without NHA then perfused for 4 days. * Indicates p<0.05
2.3.2. High Molecular Weight Hyaluronan Bolsters Barrier Integrity
Experiments were conducted to determine the dynamics of barrier integrity
following cessation of fluid shear stress to mimic the occlusion of cerebral blood flow
during acute ischemic stroke. Vessels were exposed to 0.7 dyn/cm2, the minimum level of
shear stress required for barrier formation, for four days prior to stopping flow (at time =
0) and evaluating permeability at 20, 60, 120, and 240 minutes. As Figure 2A indicates,
the permeability of the 3D vessels significantly increased at the 120 and 240-minute
timepoints following removal from flow. These experiments were also conducted in
hydrogels without high molecular weight hyaluronan (HMW-HA) to determine the
importance of matrix formulation on flow-mediated barrier integrity. As Figures 5A and
5B indicate, vessels fabricated in collagen-only hydrogels exhibited a significantly higher
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permeability at the initial measurement time, and there was no significant change in
permeability in the four hours that followed. These results suggested that the presence of
HA contributed to flow-mediated barrier formation and maintenance.
Because CD44 is one of the main transmembrane receptors for HA,
immunocytochemistry was performed on vessels patterned in both collagen/HA and
collagen- only scaffolds and exposed to 4 days of 0.7 dyn/cm2 shear stress. Figures 5C–E
provide images of these vessels and show increased CD44 localization to cell-cell
junctions in vessels patterned in collagen/HA scaffolds, whereas the receptor is diffuse
throughout the cytoplasm and does not localize as strongly to cell-cell junctions in
collagen-only hydrogels. Side views of the vessels in collagen-only hydrogels reveal
positive CD44 staining on the apical side of the endothelium where there is likely a
robust glycocalyx layer (Figure 5C(iii)). Conversely, positive staining is observed in both
apical and basal sides in collagen/HA hydrogels, suggesting that the location of the
receptor is crucial for the observed flow response (Figure 5Diii, Eiii). Quantification of
message levels of CD44 exhibited no significant difference in expression between flow
and static conditions in the collagen/HA hydrogels (Figure 6).
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A Permeability measurement taken after 4 days of perfusion and during 4 hours after
flow stoppage. B Permeability coefficients measured using 4kDa dextran after 4 days of
perfusion for channels in a collagen or collagen/HA hydrogel. C Localization of CD44 in
vessels patterned in a collagen-only hydrogel and stained for DAPI (blue), phalloidin
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ii) and in cross-section (iii). Scale: 20µm. D Localization of CD44 in vessels patterned in
a collagen/HA only hydrogel exposed to static conditions E Localization of CD44 in
vessels patterned in a collagen/HA only hydrogel exposed to flow conditions Scale:
20µm. * indicates p<0.05 between collagen and collagen/HA scaffolds at each time point,
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2.3.3. CD44 Expression and Downstream Signaling Mediates Shear
Mechanotransduction
In order to further interrogate the role of CD44 in flow mechanotransduction,
hCMEC/D3 cells were genetically modified using the CRISPR/Cas9 system to knockout
expression of the receptor. A CRISPR/Cas9 plasmid containing a scrambled guide
sequence was used as a control for these experiments. Double nickase plasmids were
used to knockout CD44 [82]. Western blotting validated the effect of gene editing on
CD44 expression (Figure 7A). Live/dead and BrdU assays were also conducted to assess
the effect of CD44 knockout on viability and proliferation. Figure 8 shows that knockout
did not significantly affect viability, but the number of cells in S phase were significantly
less than the scrambled condition, suggesting a reduced rate of proliferation. Both FITCdextran permeability assays (Fig. 7B) and daily TEER measurements (Fig. 7C) indicated
that reduced CD44 expression mitigated barrier formation in response to 0.7 dyn/cm2 of
shear stress. In both assays, the scrambled control had significantly higher barrier
function compared to the other conditions. Vessels treated with scrambled guide
sequences exhibited ZO-1 localization to the cell-cell junctions with minimal perinuclear
localization (Fig. 7D). The transformed cells did not exhibit different barrier integrity
compared to normal cells determined by permeability and TEER measurements
(Figure9). Vessels seeded with CD44-knockdown cells and exposed to flow exhibited
reduced localization to the cell-cell junctions of both ZO-1 and adducin-γ, an actincapping protein [83] associated with linking actin to the cell membrane (Fig. 3D, E).
Given that previous studies have found CD44 activation affects small GTPases associated
with cell mechanotransduction [60], GTPase activity was examined using ELISA assays
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for both scrambled and knockout conditions in vessels exposed to shear stress. In order
to produce a sufficient protein yield to use the ELISA assay, a larger diameter vessel (1mm), which has been previously used for high Reynolds number studies [46], was
endothelialized and exposed to 2.1 dyn/cm2 of shear stress, the minimum level of steady
shear stress capable of being applied to the cells in this configuration. Figure 9A
provides a confocal stack of the larger vessel, and Figure10B verifies the localization of
ZO-1 to the cell-cell junctions in response to shear stress in this geometry. Significantly
elevated levels of RhoA-GTP were detected in CD44 KO vessels compared to scrambled
controls (Fig. 7F). Conversely Rac1-GTP levels were reduced in CD44 KO vessels (Fig.
7G). These results demonstrate that CD44 expression differentially regulates RhoA and
Rac1 activation in endothelial cells exposed to fluid shear stress. Moreover, the
combination of CD44 expression, HA in the extracellular matrix, and fluid shear stress
are required for barrier formation in the 3D blood-brain barrier model.
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to flow (D) and knockout cells in collagen/HA hydrogels exposed to flow (E). Scale:
50µm (F) Relative intensity (RQ) of RhoA activation in channels measured with ELISA.
(F) Relative intensity (RQ) of Rac1 activation in channels measured with ELISA. *
Indicates p < 0.05.
30

DAPI
GFP
PI

A

Scrambled

Scrambled
DAPI
GFP
PI

B

E

CD44KO

C

DAPI
BrdU

CD44KO

F

100

BrdU− positive cells(%)

75
Viable cells (%)

DAPI
BrdU

D

50

25

20

*

10

0

0

Scrambled

CD44 KO

Scrambled

CD44 KO

Supplemental Figure 4: Viability and proliferation assays in
CD44-KO
cells. A-B Fluorescent
of cells
transformed
Figure 8. Viability
and Proliferation
Assays in images
CD44-KO
Cells.
A-B Fluorescent images
with CRISPR encoding A scrambled or B CD44-knockout
of cells transformed with CRISPR encoding Scrambled (A) or CD44-knockout (B)
plasmids stained with DAPI (blue), GFP (green), and Propidium
vectors stained with
DAPI
(blue),
GFP100μm.
(green),
and Propidium
iodide
(PI)(red). Scale:
iodide
(PI) (red).
Scale:
C Quantification
of cell
viability.
100µm. C Quantification
of cellimages
viability.
D-Etransformed
Fluorescent
of cells transformed
D-E Fluorescent
of cells
withimages
CRISPR
encoding
D
scrambled
or
E
CD44-knockout
plasmids
stained
with CRISPR encoding Scrambled (D) or CD44-knockout (E) vectors stained with DAPI
with DAPI (blue) and BrdU (red) following 12-hour incubation in
(blue) and BrdU (red)
following 12-hour incubation in media containing 10µM BrdU.
media containing 10μM BrdU. Scale: 250μm. F Quantification of
Scale: 250µm. F Quantification
of cells
staining
positive
for BrdU. * Indicates p<0.05
cells staining positive
for BrdU.
* indicates
p<0.05.

31

A

B
1250

1000

0.3

TEER (Ωcm2)

Permeability (10−6 cm s)

0.4

0.2

Normal
CRISPR Scrambled

750

500

0.1
250

0.0

Normal

Day 1

CRISPR Scrambled

Day 2

Day 3

Day 4

Time

Supplemental Figure 5: Barrier integrity of normal and transformed hCMEC/D3. A Permeability coefficient
measured in channels seeded with hCMEC/D3, normal and transformed with CRIPSR scrambled plasmids
cultured9.forBarrier
4 days. BIntegrity
TEER measurement
for channels
seeded with hCMEC/D3
both normal and transformed
Figure
of Normal
and Transformed
hCMEC/d3.
with CRIPSR scrambled plasmid.

A Permeability coefficient measured in channels seeded with hCMEC/d3, normal and
Transformed with CRIPSR scrambled vector cultured for 4 days. B TEER measurement
for channels seeded with hCMEC/d3 both normal and transformed with CRIPSR
scrambled vector. No significance p<0.05 between the two conditions tested with
ANOVA followed by Tukey post-hoc test.
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Figure 10. ZO-1 Localization in Cell Monolayers used for Immunoprecipitation and
ELISA Experiments. A 3D confocal scan of the 1-mm diameter vessel. B hCMEC/D3
stained for DAPI (blue), phalloidin (green), and anti-ZO-1 (red) (isolated in ii) after
exposure to 2.1 dyne/cm2 in the enlarged vessel. C Schematic of rheometer setup used to
apply fluid shear stress to 2D cultures. D-E Monolayers stained for DAPI (blue),
phalloidin (green), and anti-ZO-1(red) (isolated in ii) for static (D) and shear € conditions
after 24 hours. Scale = 25 µm.

2.3.4 RhoA Inactivation and Rac1 Activation Increase Barrier Integrity in Response to
Flow
Having demonstrated that CD44 expression alters RhoA and Rac1 activation in
the presence of fluid shear stress, studies were conducted to directly assess the effect of
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shear stress on small GTPase activation. The consequences of RhoA activation on bloodbrain barrier integrity have been extensively studied [49, 61, 84-88], but flow-mediated
regulation of RhoA and Rac1 activity in cerebral endothelial cells has not been clarified.
Both pull-down and ELISA assays were used to evaluate RhoA and Rac1 activity in
vessels exposed to fluid shear stress. In order to generate sufficient protein for a pulldown assay, cells were seeded on the surface of the collagen/HA formulation used in the
3D model and placed in a cone and plate rheometer to apply shear stress (Supplemental
Figure 6C). In the 2D configuration, ZO-1 exhibited reduced localization to cell-cell
junctions in static conditions (Supplemental Figure 10D) compared to 2.1 dyn/cm2 shear
stress (Supplemental Figure 10E). The application of 2.1 dyn/cm2 significantly reduced
the level of RhoA activity (Fig. 11A). This result was confirmed using the large diameter
3D vessels and ELISA assays used previously (Fig. 11B). Both assays indicated a
reduction of nearly 50% compared to static controls. An ELISA was also conducted for
Rac1 and found that Rac1 activation was significantly increased at both the 6-hr and 24hr time points following the start of perfusion (Fig. 11C). These assays indicate that shear
stress causes differential expression of RhoA and Rac1, significantly reducing RhoA
activation while increasing Rac1 activation.
In order to verify the importance of small GTPase activation for regulating barrier
integrity in the 180-µm geometry, vessels were treated with a Rho inhibitor (C3
transferase) for four hours prior to stopping flow or treated with a Rho activator in the
last four hours of the four-day perfusion with 0.7 dyn/cm2 of shear stress.
Immunocytochemistry showed that modulating RhoA activation had a substantial effect
on the morphology of the endothelial cells. Figure 4D shows strong ZO-1 localization to
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the junction following 240 minutes of no flow in the presence of C3 transferase.
Additionally, adducin-γ, which previous studies have identified as a downstream target of
small GTPase signaling [89], also exhibited increased localization to the junction in this
condition (Fig. 11D, iii). In contrast, exposure to Rho activator resulted in barrier
disruption and increased perinuclear staining of ZO-1 and adducin-γ at the end of the
four-day perfusion period (Fig. 11E). FITC-dextran permeability testing with vessels
perfused with the Rho inhibitor exhibited no significant increase in permeability, as
shown in Figure 11F. In contrast, the permeability at the end of the four-day perfusion
was significantly higher in vessels treated with the Rho activator (Fig. 11G). hCMEC/D3
cells in culture were treated with RhoA activator for four hours to determine whether
RhoA activation affected CD44 expression. Figure 12 indicates that treatment with RhoA
activator significantly reduced message levels of CD44, suggesting potential feedback
between CD44 and RhoA activation. An additional experiment was conducted to
determine whether RhoA inhibition could recover permeability in vessels seeded with
CD44 knockout cells. Vessels were perfused for four days, and then flow was halted and
C3 transferase was added to the culture medium. Figure 13 shows that inhibiting RhoA in
knockout vessels did not produce a functional barrier, which highlights potential
differences in the effect of small GTPase signaling in barrier formation versus barrier
maintenance.
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Figure 11. Fluid Shear Stress Mediates Rac1 and RhoA Activation. A RQ of activated
RhoA to total RhoA isolated using Rhotekin-mediated pulldown. B Relative intensity
(RQ) of RhoA activation in channels exposed to flow measured with ELISA. C Relative
intensity (RQ) of Rac1 activation in channels exposed to flow measured with ELISA.
*Indicates p<0.05 compared to the static condition. D-E Fluorescent images of vessels
stained with DAPI (blue), ZO-1(red) (isolated in ii), and adducin (magenta) (isolated in
iii) for C3 Transferase (D) and Rho Activator (E). Scale: 50µm. F Permeability
coefficients of channels perfused for 4 days then incubated with C3 Transferase for 4
hours prior to flow stoppage. * Indicates p<0.05 compared to the control condition for
each time point. G Permeability coefficients of channels perfused for 4 days then exposed
to a Rho Activator for 4 hours prior to flow stoppage. * Indicates p < 0.05.
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Figure 13. Permeability in KO Vessels Exposed to RhoA Inhibition.
A Permeability coefficient measured in channels seeded with hCMEC/d3, Transformed
with CRIPSR scrambled and CD44 KO vectors cultured for 4 days under flow
conditions. 2µg/ml C3 transferase was added to the CD44KO vessels 4 hours prior to
permeability measurements. * Indicates p<0.05
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2.3.5 Adducin-γ Localization is a Downstream Effect of Rac1 Activation.
Given that adducin-γ localization to cell-cell junctions was affected by both CD44
expression and RhoA inhibition, experiments were conducted to determine the
importance of this actin-capping protein to flow-mediated barrier formation. Previous
studies have shown that adducin contributes to tight junction stability in human epithelia
cells [83], but the effect of fluid shear stress on adducin-γ has not been studied. As
Figures 14A-B indicate, the localization of adducin-γ to the junctions was altered in
vessels exposed to 0.7 dyn/cm2 shear stress compared to static controls. In order to
determine whether a tight junction-associated complex incorporating adducin-γ formed in
response to flow, ZO-1 immunoprecipitation was performed. To produce sufficient
protein for the pulldown, hCMEC/D3 cells were seeded on the surface of collagen/HA
hydrogels and placed in a cone and plate rheometer to apply a steady shear stress of 0.7
or 2.1 dyn/cm2. As Figure 14C indicates, the application of shear stress resulted in
significantly higher levels of adducin-γ in the ZO-1 pulldown compared to static controls.
Significantly increased levels of spectrin-αII bound to the ZO-1 complex were also
measured in response to shear (Figure 15), consistent with previous findings that spectrin
binds to adducin [90].
To interrogate the importance of adducin-γ expression during blood-brain barrier
formation, siRNA was used to knockdown message levels of the protein in the
hCMEC/D3 cells prior to seeding within the vessels (Figs. 14D-E). Knockdown
efficiency was measured 5 days after transfection to ensure that in vitro vessels seeded
with treated endothelial cells would express reduced levels of adducin-γ throughout the
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perfusion period. Permeability testing of vessels containing the knockdown cells
exhibited significantly higher permeability compared to scrambled controls (Fig. 14F).
Taken together, these results suggest that recruitment of adducin-γ to cell-cell junctions is
an integral downstream result of fluid shear stress application to cerebral endothelial cells
and that both CD44 expression and small GTPase activity alter its localization.

Figure 14. Adducin-γ Regulates Tight Junctional Stability Through Association with ZO1. A-B Fluorescent images of vessels stained with DAPI (blue), phalloidin (green), ZO-1
(red), and add-γ (magenta) (isolated in ii) for flow (A) and static (B) conditions. C
Immunoprecipitation of the ZO-1 complex from cells exposed to static and flow
conditions. D Relative intensity of add-γ bound to ZO-1 isolated using IP and measured
with western blot. Scale: 25µm, * indicates p<0.05 compared to static condition. E
Western blot of cells treated with DsiRNA targeting add-γ. F Relative intensity of add-γ
in DsiRNA and control cells normalized to beta-actin. G Permeability coefficients
measured in channels seeded with add-γ knockdown (KD) hCMEC/d3 cells * indicates
p<0.05 compared to control.
39

Figure 15. IP Pulldown of ZO-1 Binding Complex.
Ai Spectrin-αII isolated using IP from hCMEC/d3 seeded on a monolayer exposed to 24
hrs. of flow. B Fold change of Spectrin-αII /ZO-1 normalized to static condition
2.4 Discussion
Our results identify components of a previously unreported signaling transduction
pathway that mediates blood-brain barrier formation in response to fluid shear stress.
These findings identify CD44 as a mechanosensor that localizes to cell-cell junctions in
response to shear stress and the presence of HMW-HA in the ECM. Shear stress results in
activation of Rac1 and inhibition of RhoA, and induces a complex including ZO-1,
adducin-γ, and spectrin-αII at the junctions (summarized in Figure 16). Our findings
suggest that a threshold level of shear stress is needed to activate this pathway, given that
levels of shear stress less than 0.7 dyn/cm2 were unable to significantly increase barrier
formation and maintenance during perfusion. Moreover, CRISPR-mediated alteration to
CD44 levels suggest that all three components: hyaluronan, CD44, and shear stress are
required for barrier formation in the 3D BBB model. Our study concludes that this
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mechanism is integral to blood-brain barrier mechanotransduction, identifying an
alternative mechanosensory complex of shear stress exerted by cerebral blood flow [51].
The role of CD44 in mechanotransduction has been well-studied [91], but its
importance for sensing shear stress has yet to be investigated in detail. A previous study
using bovine aortic endothelial cells found that inhibiting hyaluronan synthesis negated
flow-mediated cell spreading on soft (100 Pa) two-dimensional substrates [92],
suggesting that CD44 may mediate cytoskeletal processes in response to shear stress.
Here, the importance of CD44 was initially revealed due to the difference between
vessels fabricated in collagen-only and collagen/HA hydrogels. There was a significantly
lower permeability in collagen/HA hydrogels where CD44 was present on both apical
and basal sides, compared to collagen-only hydrogels where CD44 was only present on
the apical side, likely due to the presence of the glycocalyx. Previous studies have
demonstrated the importance of the glycocalyx in flow mechanotransduction, and vessels
fabricated in collagen-only hydrogels still have a significantly lower permeability than
static controls after perfusion. Yet, our results demonstrate that the presence of HA in the
ECM yields a significantly lower permeability, demonstrating the importance cell-matrix
adhesions for mediating the flow response.
The CD44 knockout studies show that the cell surface receptor differentially
regulates RhoA and Rac1 when exposed to fluid shear stress. Furthermore, the ELISA
and pulldown experiments confirmed that fluid shear stress significantly increased the
activation of Rac1 while attenuating the activation of RhoA, providing further evidence
that the activity of these small GTPases is affected by shear stress. The activation of
RhoA has been shown to induce cell contractility and cytoskeleton restructuring,
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resulting in enhanced cell motility and disrupted barrier integrity. Conversely, Rac1 has
been identified as a key mediator of vascular integrity in systemic vasculature [44, 93].
Previous studies have shown that CD44 can activate these small GTPases [55, 60], but
the results presented here are the first to demonstrate that this signaling is
mechanosensitive.
Another crucial component of the signaling mechanism involves adducin-γ
localization to tight junctions in the presence of shear stress. Adducin-γ has been shown
in previous work to stabilize the cytoskeleton [89] and cell-cell junctions [83] , and is a
ROCK substrate [90, 94]. Studies have found that adducin-γ is an important component
of both adherens and tight junctions within endothelial cells, and that it mediates cAMP
signaling [25]. Additionally, the increase in spectrin-αII bound to the tight junction
complex in response to flow indicates a potential role in stabilization of the tight-junction
complex. Previous studies have identified the ankyrin-adducin-spectrin complex, which
binds to transmembrane proteins bridging the gap to the cytoskeleton [95]. Specifically,
spectrin-αII is associated with the brain and its cleavage products are a potential
biomarker for neurodegenerative disorders [96]. These findings indicate that that the
association of adducin-γ and spectrin-αII may contribute to barrier function, yet
additional studies are required to explicitly determine how the activity of RhoA and Rac1
affects the localization of these proteins in cell-cell junctions. Nonetheless, the
knockdown studies suggest that adducin-γ is required to maintain blood-brain barrier
integrity, since reducing its expression resulted in increased permeability and barrier
disruption. Clinical studies have identified adducin-γ as a factor that can contribute to
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altered cerebral vascular function [97], providing further evidence of its importance in
maintenance of the blood-brain barrier.
Taken together, these results demonstrate a new mechanism by which fluid shear
stress is transduced by endothelial cells within the blood-brain barrier. Future work is
required to investigate crosstalk between this pathway and previously studied
mechanosensitive mediators of vascular integrity [35, 44, 47, 98], given recent studies
showing that PECAM also affects blood-brain barrier integrity [99], and to determine
ways in which this mechanism can be manipulated in vivo. Moreover, although this study
focuses on paracellular transport, additional studies can interrogate the effect of this
mechanosensitive pathway on transcellular transport [100] in the blood-brain barrier.
Furthermore, a limitation of the 3D-BBB model is its difficulty assessing how certain
factors affect barrier formation and maintenance distinctly. For example, although we can
evaluate whether shear stress is needed to both form and maintain the barrier by tuning
the flow rate, the matrix composition can only be tuned at the time of fabrication, not
after four days of perfusion culture. The inability to evaluate formation and maintenance
distinctly was apparent in the finding that inhibition of RhoA with C3 transferase
treatment for four hours did not recover barrier function in vessels consisting of CD44KO cells: knocking out CD44 prevents the initial barrier formation that RhoA inhibition
is able to maintain in scrambled controls. Finally, an additional limitation of the current
study is its use of the immortalized hCMEC/D3 cell line; further studies are required to
determine whether this CD44-small GTPase-adducin mechanism is present in primary
cells or induced pluripotent stem cell-derived endothelial cells exposed to fluid shear
stress.
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Figure 16. Mechanosensitive CD44 Helps Stabilize Tight Junctions Through Activation
of Rac1 and Inactivation of RhoA. A CD44 bound to HA transduces fluid flow. B The
application of shear stress activates Rac1 while inactivating RhoA. C Activation of Rac1
leads to the recruitment of add-γ and ZO-1 to the cell-cell junction. D add-γ and ZO-1
form a binding complex with spectrin-αII that stabilizes tight junctions required for the
blood-brain barrier.
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Chapter 3
SARS-Cov-2 Spike Protein Disrupts Blood-Brain Barrier Integrity Via RhoA
Activation [101]
3.1 Introduction
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the virus that causes coronavirus disease 2019 (COVID-19), has caused significant
morbidity and mortality at a global scale [102]. Although widely considered a respiratory
disease, studies have reported detrimental effects of the virus on multiple organ systems
including the central nervous system (CNS) [102-104]. Delirium has become a common
symptom among older adults with COVID-19 infection, presenting in 20-30% of patients
with rates as high as 70% among severe cases [103, 105]. Delirium is characterized by
sudden onset of dysphoria and disturbed attention in patients with no history of
neurological complications [103, 106]. Since previous studies have correlated delirium
with breakdown of the blood-brain barrier [106], these clinical outcomes suggest that the
SARS-CoV-2 is either directly or indirectly disrupting the blood-brain barrier.
Cellular infection by SARS-CoV-2 is mediated by its viral spike protein binding to
angiotensin-converting enzyme 2 (ACE2), which is expressed throughout the
endothelium in the body including vascular beds of the kidneys, lungs, and heart [103,
107]. Studies have also confirmed the presence of ACE2 in cerebral vasculature,
supporting clinical evidence of neuroinvasion [65, 108]. ACE2 is a cell surface
carboxypeptidase that converts angiotensin II (Ang-II) to angiotensin fragment 1-7(Ang
1-7) as part of the renin-angiotensin system (RAS), promoting vasodilation and decreased
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hypertension[109]. Yet, the downstream effects of spike-ACE2 binding and the
mechanisms underlying barrier disruption in response to spike protein remain unclear.
Previous studies have suggested that the SARS-CoV-2 virus increases the expression of
ACE2 [68], providing a means for the virus to amplify infection. Similarly, the
application of shear stress to vascular endothelial cells showed a transient increase in
ACE2 expression [69]. However, no study has explored the role of ACE2 in barrier
forming endothelial cells.
In the present study, a three-dimensional model of the BBB [39] was utilized to
examine the role of ACE2 and SARS-CoV-2 spike protein on BBB homeostasis. The
model employs human cerebral microvascular endothelial cells (HCMEC/d3) [72] in
combination with fluid shear stress in a collagen/HA hydrogel matrix in order to mimic
the human blood-brain barrier. This platform enables the real time assessment of BBB
function in response to spike protein such as permeability and transendothelial electrical
resistance (TEER) measurements. Here, evidence suggests that barrier breach in response
to SARS-CoV-2 spike protein is RhoA-mediated and inhibition of RhoA can mitigate
BBB hyperpermeability.
3.2 Methods
3.2.1. In Vitro Blood-Brain Barrier Models
Three-dimensional models of the blood-brain barrier (3D BBB) were fabricated as
described previously [39]. Hydrogels composed of 5 mg/mL type I collagen, 1 mg/mL
HA(>1MDa), 1 mg/mL Matrigel were created within microfluidic devices. Prior to
polymerization, 180-µm needles were removed to create voids, and HCMEC/D3 (P2246

P23) (provided by the laboratory of Dr. Robert Nagele) were injected at a density of 10
million per mL (10 µL per channel). Following cell seeding, channels were either
exposed to flow using a linear syringe pump (Kent Scientific) or incubated in static
conditions in a 6-well plate. For GTPase activity assays, a larger diameter (1-mm) model
was used to generate sufficient protein quantities [46]. For ACE2 protein expression
assays, the same hydrogel formulation was polymerized on treated PDMS coated plates,
and HCMEC/D3 were seeded on the gel at a density of 4k/cm2. Monolayers were
incubated for 3 days in static culture to ensure confluency, then exposed to fluid shear
stress. Fluid shear stress was applied using a 40-mm 1-degree cone plate on a rheometer
(TA Instruments) for 24-hrs on a Peltier plate set to 37oC. The media was supplemented
with HEPES buffer to a final concentration of 10 mM to maintain physiological pH.
3.2.2. Permeability Assessment
After exposure to experimental conditions, channels were perfused with 4-kDa
dextran-FITC at a flow rate of 5 µL/min using a syringe pump for 10 minutes. This flow
rate was selected to assure fully developed flow throughout the majority of the channel
and to maintain consistency with previous work [39]. Images were taken at 30-s intervals
for 10 minutes, and the diffusion coefficients were established using the following
equation from previous work [75].
!" $
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!

Sample numbers of at least n = 3 were used to determine the mean and standard deviation
for each condition.
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3.2.3 Transendothelial Electrical Resistance (TEER) Measurements
TEER measurements by impedance spectroscopy were obtained using a stingray
DS1M12 USB oscilloscope adapter (USB Instruments) that measured current across a
reference resistor for a range of frequencies. Impendence, defined as Z=V/I, was
measured at 15-Hz, where capacitance of the electrodes dominates and 15.6-kHz, where
resistance of the culture media dominates [76]; the difference between these two values
yielded the TEER measurement. These values were normalized using the impedance of
an acellular hydrogel within the microfluidic device.
3.2.4 SARS-CoV-2 Subunit S1 Exposure
Following 4 days of perfusion, vessels were exposed to EGM-2 supplemented
with 50nM recombinant SARS-CoV-2 subunit S1 (Ray Biotech) for three hours. In some
cases, Rho Inhibitor, I (C3 Transferase) (Cytoskeleton) was added in addition to the S1
protein. TEER measurements were taken at 0-hr, 1.5-hr, 3-hr with dextran permeability
measurements taken at 0-hr and 3-hr time points.
3.2.5 Immunocytochemistry
Vessels were fixed in 4% paraformaldehyde (Alfa Aesar) for 30 min at room
temperature. Following fixation, the hydrogel was removed from the device and placed in
0.1% Triton X-100 to permeabilize the cell membrane. Gels were blocked in 5% normal
donkey serum and 3% BSA for 30 minutes at room temperature followed by incubating
overnight with primary antibodies for either angiotensin converting enzyme II (ACE2)
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(Santa Cruz) or zonula occludin-1 (ZO-1) (CST). Following primary incubation, gels
were washed with PBS then incubated with the appropriate secondary antibody
conjugated to Alexa 555 (CST) or Dylight 650 (Thermo Scientific). Gels were counterstained with DAPI to label nuclei and FITC-phalloidin for actin. All gels were imaged
using a Nikon A-1 confocal scanning microscope.
3.2.6 ACE2 Knockdown
SMART pool siRNA (Horizon Discovery) was used to knockdown ACE2
expression in HCMEC/D3 cells. Cells were plated in a 6-well plate at 250k per well.
When cells reached 60-70% confluency, siRNA was added according to the
manufacturer’s protocol. Knockdown efficiency was verified using western blotting after
the cells were cultured in a well plate for 96 hours, since this period matched the timing
of permeability testing in the 3D-BBB model.
3.2.7 ELISA-Based Quantification of Small GTPase Activity
Commercial ELISA kits were purchased from Cytoskeleton (G-LISA) to quantify
RhoA activation (Cytoskeleton). Cell lysates were prepared using Cytoskeleton’s
protocols. Following exposure to flow with and without S1 peptide (Ray Biotech), the
hydrogel was removed from the device and washed in ice cold 1x PBS for 30 seconds. 80
µL of ice-cold cell lysis buffer with 1x protease inhibitor was injected into vessels and
collected in a microcentrifuge tube. The cell lysate solution was spun at 10,000 g for 1
minute at 4oC to pellet cell debris. Prior to measuring GTPase activity, samples were
thawed in a room temperature water bath and equilibrated to 0.5mg/mL.
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3.2.8 ACE2 Expression
Quantification of ACE2 expression was performed using lysates extracted from
cell monolayers cultured on hydrogels exposed to 24hrs of fluid shear stress applied by a
cone and plate rheometer. 50mM SARS-CoV-1 subunit S1 was added during the final 3
hours of flow. Cell lysates were separated using a tris-glycine gel (Invitrogen) in trisglycine running buffer (Invitrogen). Separated protein was transferred to 0.45-µm PVDF
membrane (Invitrogen). The membrane was probed over night with ACE2 (Santa Cruz
Biotech) (1:250) and beta-Actin (1:400) (Santa Cruz Biotech) antibodies and visualized
with anti-mouse HRP conjugated secondary antibodies (1:4000) (Azure).
3.2.9. Statistical Analysis
The open-source statistics package, R, was used to perform all statistical calculations.
Data sets were tested for normality with Shapiro-Wilk tests prior to testing for
significance. One and two-way ANOVA tests followed by Tukey HSD post-hoc
comparisons were used to evaluate significant differences between multiple conditions.
All two sample comparisons were made using 2-tailed Student’s t-tests. Each statistical
test used sample numbers greater than or equal to 3 unless otherwise noted and p < 0.05
was considered significant. All error bars indicate standard deviation of the mean.
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3.3 Results
3.3.1 Fluid Shear Stress and SARS-CoV-2 Alter ACE2 Expression.
Previous results have demonstrated that ACE2, the main viral binding target of
the SARS-CoV-2 spike protein, is expressed by endothelial cells in the brain[65]. In
order to demonstrate that the enzyme is also expressed by HCMEC/D3 cells in our 3D
BBB model, microvessels were cultured for 96 hours under constant perfusion with 0.7
dyn/cm2 shear stress to establish barrier function. During the final 3 hours, vessels were
exposed to three different conditions: (i) flow cessation1 (static conditions) (ii) no change
in flow (continuation of flow with a shear stress of 0.7 dyn/cm2) or (iii) continuation of
flow with the addition of 50 nM SARS-CoV-2 spike S1 subunit. ACE2 staining was
present in the vessels in all of the conditions (Figs. 1A-C). These images show the effect
of shear stress and S1 spike protein on the morphology of the endothelial cells lining the
in vitro vessel and localization of ZO-1, a tight-junction scaffolding protein, to the cellcell junctions [81]. After 4 days of perfusion, vessels exposed to 3 hours of static
conditions (Fig. 1A) exhibited a substantial amount of perinuclear ZO-1 staining, with
irregular localization to the junctions. In contrast, the vessel exposed to 0.7 dyn/cm2,
indicated clear localization of ZO-1 to the cell-cell junctions without any gaps in the
endothelial monolayer (Fig. 17B). Addition of the spike protein disrupted the monolayer
and localization of ZO-1 at the cell-cell junctions in a manner similar to static culture
(Fig. 17C). Due to the limited number of cells in the 3D microvessel model, we utilized a
2D rheological model for quantification of ACE2 protein levels, which maintained the
extracellular matrix properties of the 3D configuration (Fig. 17D). ECs were exposed to
2.1 dyn/cm2 of shear stress in a 2D geometrical configuration for 24-hours, after three
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days of culturing to allow the monolayer to reach confluency. The relative quantity of
ACE2 was normalized to the static condition. Exposure to shear stress significantly
decreased the level of ACE2 expression in the monolayers compared to static conditions
by approximately 60%. However, addition of the spike protein under flow resulted in the
upregulated expression of ACE2, so that there was no significant difference with static

2D geometry for WB assays

3D geometry for permeability, TEER, IF assays

conditions (Fig. 17E).

Figure 17. ACE2 Expression. A-C Fluorescent images of 3D vessels stained with DAPI
(blue), Phalloidin (green), ZO-1(red) (isolated in ii) and ACE2 (magenta) (isolated in iii)
for 3 conditions: Static(A), Flow(B), (C)Flow + S1 subunit exposure for 3 hours. D
Schematic of rheometer setup used to apply fluid shear stress to 2D cultures for protein
expression assays. Ei Western blot of cells exposure to static, flow, or flow+ S1 protein
(3hr) (i). Eii Ratio of ACE2 and beta-actin from Ei normalized to a flow sample. *
Indicates p<0.05 compared to flow. n=3 for all experiments
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3.3.2 ACE2 Expression Contributes to Shear Stress-Mediated Blood-Brain Barrier
Formation
Previous studies have shown that SARS-CoV-2 spike protein promotes
endothelial dysfunction when bound to ACE2 [110]. Therefore, ACE2 knockdown was
conducted to determine whether its expression has any observable effect on barrier
integrity. siRNA was used to achieve 40-50% reduction in protein expression in the
HCMEC/D3 cells (Figs. 18A, i). Knockdown efficiency was measured 5 days after
transfection to match the timing of the permeability tests in the 3D model (Fig. 18A, ii).
Analysis of permeability containing the knockdown for ACE2 revealed significantly
higher permeability compared to the scrambled controls (Fig. 18B). The higher
permeability may be caused by disassembly of the tight junction complex and
subsequently increased paracellular transport. Immunofluorescence images confirmed
altered morphology in the presentation of the key tight junction protein, ZO-1, in cells
with reduced ACE2 expression. Specifically, ZO-1 expression lacked the typical
membrane-like expression patterned and instead showed a more diffused and displaced
cytosolic expression (Fig. 18c). These results indicate that ACE2 expression may
contribute to the integrity of the tight junction complex.
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Figure 18. ACE2 and Tight Junction Formation. Ai Western blot of cells treated with
DsiRNA targeting ACE2. Aii Relative intensity of ACE2 in DsiRNA and control cells
normalized to beta-actin. B Permeability coefficients measured in channels seeded with
ACE2-Knockdown (KD) HCMEC/D3 cells. *Indicates p<0.05 compared to control. n=3
for all experiments. C-D Fluorescent images of vessels stained with DAPI (blue),
Phalloidin (green), ZO-1(magenta) (isolated in ii) for 3 conditions: siRNA control(C),
and siRNA ACE2-KD(D)

3.3.3 SARS-CoV-2 Spike Protein Disrupts the Barrier Through RhoA.
Multiple studies have demonstrated that activation of RhoA disrupts vascular
integrity [24, 43, 61]. Therefore, we evaluated whether the spike protein could trigger
signaling events that activate RhoA. Using ELISAs that measure the active form of the
RhoA-GTPase, endothelial cells were incubated with and without the spike S1 subunit.
Figure 3A shows that 24 hours post-perfusion with the spike protein significantly
54

increased RhoA activity compared to no S1 flow only controls (Fig. 19A). Consequently,
measurements of dextran permeability (Fig. 19B) and TEER (Fig. 19C) show that
inhibition of RhoA with C3 transferase while in the presence of S1 mitigated barrier
breach. A 3-hr period was used for the evaluation of permeability and both 1.5-hr and 3hr time points were used for the TEER measurements. Immunofluorescence verified that
RhoA inhibition increased compartmentalization of ZO-1 to the cell-cell junctions in the
presence of the spike protein (Fig. 19D). Together these results show that RhoA is
activated by the SARS-CoV-2 spike protein S1 subunit leading to a compromise in
barrier integrity.
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Figure 19. Spike Protein Alters BBB Integrity. A Relative intensity (RQ) of RhoA
activation in channels exposed to flow measured with ELISA. B Permeability
measurement of vessels exposed to experimental conditions at 0-hr and 3-hr time points.
*Indicates p<0.05 compared to all conditions. C TEER values of vessels exposed to
experimental conditions at 0-hr,1.5-hr and 3-hr time points. * Indicates p<0.05 compared
to all 0-hr and 1.5-hr time points and ** indicates p<0.05 compared all other conditions.
n=3 for all experiments. D Fluorescent images of vessels treated with C3 Transferase and
S1 spike protein stained with DAPI (blue), Phalloidin (green), ACE2(magenta), and ZO1(red) (isolated in ii).
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3.4 Discussion
The results presented here provide preliminary insight into the mechanisms
underlying the effect of the SARS-CoV-2 spike protein on barrier integrity and identify
RhoA as a key mediator of spike-induced barrier disruption. We first examined the main
cellular binding target for the spike protein, ACE2. Application of fluid shear stress,
which is needed for barrier formation and constitutes a crucial physiological parameter
for the maturity of endothelial cells, results in lower levels of ACE2 expression compared
to static conditions. However, when brain endothelial cells are exposed with the S1
subunit of the spike protein, expression of ACE2 is significantly upregulated.
This result contrasts with a previous finding that fluid shear stress transiently
increases ACE2 expression, though that specific study was performed with non-brain
endothelial cells on tissue culture plastic [69]. Moreover, our results showed for the first
time a possible link between homeostatic barrier maintenance and the ACE2 protein.
Indeed, the tightness of the barrier appears to be greatly impacted in experiments in
which the expression of the ACE2 gene is knocked down (Figure 2). This result may help
to reconcile observations of the protective effects of ACE2-containing exosomes in the
aftermath of ischemia/reoxygenation injury [111]. Thus, our analysis merits a closer look
at a direct role for ACE2 in maintaining BBB tightness.
ELISA studies indicated that S1 spike protein significantly increased the
activation of RhoA, demonstrating that the small GTPase influences barrier breakdown in
response to SARS-CoV-2. The activation of RhoA has been shown to induce cell
contractility and cytoskeleton restructuring, resulting in enhanced cell motility and
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disrupted barrier integrity [61, 112]. This conclusion is supported by permeability and
TEER testing showing that the detrimental effects of S1 spike protein on the BBB are
ablated by inhibiting RhoA activation (Figure 3). Given that RhoA activates the Rho
kinase (ROCK), it is noteworthy that the therapeutic effects of ROCK inhibition have
already been considered for the treatment of severe COVID-19 [113]. In fact, preclinical
studies have shown the benefits of inhibiting the Rho-ROCK pathway to improve
pulmonary outcomes[114, 115]. Additionally, ROCK inhibitors have been shown to
protect pulmonary tissue during severe respiratory illness [113, 115]. The effects of
ROCK inhibition seems to also confer vascular protection a showing improved
neurological outcomes following ischemic stroke [116]. Perhaps a similar therapeutic
approach could be developed to prevent neurological deficits associated with COVID-19.
Additional studies are required to probe further the underlying mechanisms of
spike protein-mediated increase in ACE2 expression and RhoA activity. It has been
shown previously that binding of angiotensin II to its receptor, angiotensin II type 1
receptor, increases RhoA activity [117]. Therefore, if ACE2 is inhibited by the spike
protein of SARS-CoV-2, less angiotensin II can be converted to angiotensin fragment 17(Ang 1-7) and can potentially accumulate to increase RhoA activity. However, in the
context of these in vitro studies, it is unclear how much angiotensin II is present within
the fetal bovine serum used to supplement the culture medium used in these experiments.
It is also possible that spike binding to ACE2 directly activates signaling pathways
through the cytoplasmic tail of ACE2, given that previous studies have found binding
sites in this region for calmodulin, an important mediator of cytoskeletal processes [118].
Future studies can be conducted in the presence of physiological levels of angiotensin II
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to more completely elucidate how the interplay between the SARS-CoV-2 spike protein,
ACE2, RhoA activation and barrier disruption.
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Chapter 4
Microindentation of fluid-filled cellular domes reveals the contribution of RhoAROCK signaling to multicellular mechanics [119]
4.1 Introduction
Several approaches have been developed to interrogate the mechanics of
multicellular sheets due to their role in mediating a variety of physiological processes,
specifically in membranes and barriers in the body. In contrast to single cells plated on
two-dimensional substrates or embedded within extracellular matrix, many of these
methods must take into account the force that cells in multicellular structures exert
through both cell-cell junctions as well as cell-matrix adhesions[120]. Monolayer stress
microscopy is an example of such an approach; it tracks the displacement of fiducial
markers on the substrate as well as cell morphology and migration, facilitating in-depth
observations of temporal and spatial fluctuations of the mechanical forces experienced
and exerted by individual cells within collective regions[121-123]. These studies have
revealed that development and redistribution of dynamic tension gradients are influenced
by cell-substrate interactions and by biophysical changes at intercellular junctions that
induce signaling cascades[47, 123-126].
Isolating the effects of cell-cell and cell-matrix tension has been made possible by
techniques that suspend cell sheets between pillars[1, 127, 128]. The cell sheets have a
thin basement membrane that cannot provide mechanical resistance to actomyosin
contractility, and thus cells exert force primarily through cell-cell junctions[1, 129, 130].
Measuring force-displacement curves of multicellular structures in this way has revealed
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their collective, non-linear mechanical properties[131, 132]. Another means to study
multicellular mechanics involves the formation of fluid-filled cellular domes: epithelial
cells express apicobasal transporters that actively pump metabolites, thereby generating
pressures that form dome-like structures and yield heterogenous cellular strain patterns
dependent on the degree of cell stretching across the surface[120, 133, 134]. The dome
model exhibits hyperelastic-like behaviors such as strain softening from depleted actin
availability, and re-stiffening at increasing loads with the support of intermediate
filaments to offset the tension generated as cells were stretched[120]. A similar approach
involves the formation of epithelial cysts, which exhibit viscoelastic behavior when
compressed with an atomic force microscopy[135]. This previous work validates the use
of domes and other fluid-filled structures to characterize the mechanical properties of
multicellular structures.
However, previous studies have yet to use domes and fluid-filled cysts to
simultaneously investigate the mechanical properties of cell monolayers during
deformation and the contribution of cell contractility to stress relaxation. Here,
indentation of the domes with a micro-tensiometer characterizes the mechanical
properties of multicellular sheets during deformation, and also reveals the effect of cellgenerated forces on relaxation kinetics by holding the probe at a constant height after
deformation. Micro-tensiometers have been previously used to measure mechanical
properties of structures that are larger than single cells or small groups of cells, which are
better characterized by atomic force microscopy, and smaller than centimeter-scale tissue
samples that can be evaluated with axial mechanical testing or rheology, including
isolated glomeruli of rats and mice aortas[136]. The system has also been used to
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measure the forces mediating cell-matrix interactions during cell spreading in a threedimensional matrix[137]. Here, we interrogate whether the sensitivity and scale of microtensiometers are sufficient to measure the mechanics of cell monolayers by deforming
multicellular domes.
Whereas previous studies of domes and fluid-filled cellular structures used
established epithelial cell lines including Madin-Darby canine kidney (MDCK) and
human epithelial colorectal adenocarcinoma (Caco-2), our laboratory has found that
induced pluripotent stem cells undergoing a previously described differentiation
protocol[138] to produce blood-brain barrier integrity endothelial cells spontaneously
form the dome structures previously observed in epithelial cultures. This observation
supports a recent transcriptomic analysis that shows these iPSC-derived brain
microvascular endothelial cells (iBMECs) have been misidentified and actually exhibit a
phenotype that more closely matches colon epithelium[139]. Therefore, the low
permeability and high transcellular electrical resistance reported by previous groups are
not reflective of endothelial barrier tightness, but rather indicative of an epithelial-like
sheet[54, 138-140]. Regardless of what phenotype these cells match in vivo, if any, the
domes spontaneously formed by these cells exhibit a wide range of radii, yielding
multicellular structures of varying size to evaluate using the micro-tensiometer.
4.2 Methods
4.2.1 Cell Differentiation and Culture
Culture media[138, 141] was prepared using a previously described protocol for
induced pluripotent stem cells[138]. Briefly, basal medium (E4) was prepared in bulk
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because both differentiation media (E6 and E8) were prepped using E4 media. To prepare
a batch of E4 basal media, DMEM/F12 (Lonza) was supplemented with 0.014 μg/ml of
sodium selenite (Sigma-Aldrich), 1.743 mg/mL of sodium bicarbonate (Sigma-Aldrich),
and 64 µg/mL of L-ascorbic acid 2-phosphate (Sigma-Aldrich). The fabrication of E8
media includes 2 µg/mL of human insulin solution (Sigma-Aldrich), 10 µg/mL of human
holo-transferrin (R&D Systems), 0.1 µg/ml human basic fibroblast growth factor (bFGF;
Peprotech), and 2 ng/mL of transforming growth factor (TGF-β1; Peprotech). Lastly, E6
was prepared by supplementing 2 µg/mL of insulin and 10 µg/mL of holo-transferrin. All
media were sterile filtered and stored at 4 °C. E8 was stored for a maximum of 2 weeks
whereas E4 and E6 were stored for no longer than 8 weeks. Cellartis human induced
pluripotent stem cell line 7 (ChiPSC7) was purchased from Takara Bio, USA. ChiPSC7s
were cultured according to the manufacturer’s protocol in the Cellartis DEF-CS 100
culture system to expand the cells and maintain a pluripotent phenotype. Active cultures
were maintained in an incubator set to 37°C, 95% rh, and 5% CO2. P2-P3 ChiPSC7 were
grown to confluency on tissue culture plates treated with DEF-CS COAT-1 (0.1 mL/cm2)
and passaged using 20 µL/cm2 TrypLE to disassociate the cells. For cryopreservation,
cells were resuspended in cell banker at 2 × 106/mL then stored in liquid nitrogen. For
dome morphogenesis, iPSCs were replated at 25-35 ×103 cells/cm2 in culture plates
coated with 2 µg/cm2 Matrigel in E8 media supplemented with Y-27(10 µM) for 24
hours. The E8 media was replaced E6 media for 5 days daily followed by 48 hours
incubated with endothelial growth media[39] (EGM-2) (Lonza) supplemented with
10 μM all-trans retinoic acid (RA) (Sigma-Aldrich). Following incubation, dome
structures were observed in the plate and remained stable for 1 week in EGM-2+RA.
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4.2.2 Imaging
Cells intended for imaging were cultured in glass bottom culture plates to
facilities usage of high magnification objectives on a confocal microscope. Whole plates
were fixed in 4% paraformaldehyde (PFA) for 20 mins then stored at 4°C in PBS +/+.
Prior to immunostaining, plates were permeabilized in 0.2% Triton X-100 for 15 min
followed by 30 min blocking in 3% BSA and 5% normal donkey serum at room
temperature. After blocking, plates were exposed to primary antibodies targeting ZO-1
for 48 hrs. or ADD-Y, ATPASe, AQP1, TTR for 24hr at 4°C. Samples were washed
three times in PBS then incubated with secondary antibodies and counterstained with
phalloidin and DAPI prior to imagining using a Nikon A-1 confocal scanning
microscope.
4.2.3 RhoA Activation and Inactivation
In order to constitutively activate RhoA, domes were exposed to RhoA Activator
II (Cytoskeleton) at a concentration of 2 µg/mL for 3 hours prior to mechanical or
permeability testing. Domes were also treated with Y-27632 (Cytoskeleton), an inhibitor
of RhoA-associated protein kinase (ROCK), at a concentration of 50-mM for 45 minutes
prior to mechanical or permeability testing.
4.2.4 Permeability Testing
Following formation of domes the medium was supplemented with 4-kDa FITCconjugated dextran at 1:10000 to track transcellular transport and junctional integrity.
Following incubation at 37°C for 3-hrs with RhoA activator II, dome permeability was
measured with dextran-supplemented media. Images were taken at 30 second intervals
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for 10 minutes, and the diffusion coefficients were established using the following
equation from previous work [65] [75].
!" $

𝑃 = !# %&

(3)

!

where P is the permeability constant, di/dt is the rate of change in fluorescent intensity
outside the dome, r is the dome radius, and Io is the fluorescent intensity inside the dome.
4.2.5 Indentation Experiments
A Kibron cell poker fitted with a 500-µm diameter cylindrical probe indented the
domes while recording force and displacement[136]. Domes were first identified using a
Motic camera affixed to a light microscope with a 10x objective. Only domes ranging in
size from ~50-300 µm were selected for testing. Each dome was indented at a rate of 125
µm/s. Deformation was tracked with the Kibron sensor. Following initial indentation, the
probe was held in place for 30 seconds to observe any viscoelastic behavior of the domes.
To interrogate the role of different cytoskeletal components on the mechanical properties
of the domes, cells were exposed to either Y-27632 (50mM) or RhoA Activator II
(2µg/ml) for 45 minutes and 3 hours respectively prior to conducting testing as described
above.
4.2.6 Elastic Modulus and Relaxation Coefficient
The elastic modulus of the domes was calculated using Hertz contact mechanics
for a cylindrical indenter deforming a spherical half space[142]. Excel solver was used to
find an “effective” elastic modulus for the domes indicated by E*,
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where F is force, R is domes radius, and d is the indentation depth.
Time dependent relaxation was modeled using the exponential decay equation shown
here,
𝐹 = (𝐶' − 𝐶% )𝑒 01# + 𝐶%

(6)

where C1 is the initial force, C2 is the equilibrium force, and is the relaxation factor.
For both cases a least square fit was used. Solver was directed to minimize the difference
between the experimental data based on a least square fit analysis and the model equation
by altering effective modulus (E*) or relaxation factor (𝛾 ) for the contact and viscous
models respectively.
4.2.7 Mateditor Curve Fitting
Prior to creating finite element models to predict the behavior of fluid-filled
domes, 9-parameter Mooney-Rivlin models were used to fit the experimental tensiometer
data. The values from the control and y-27 conditions were inserted in an elastomer
uniaxial test to obtain the material constants needed to create a COMSOL model.
4.2.8 Mechanics Modeling
A computational model was used to predict hyper-elastic behavior of the domes over
different diameters when deformed by a rigid indenter. The commercial software,
COMSOL, was used to mesh the geometry where the hemispherical dome was filled with
an incompressible fluid (i.e., water) and adhered to a fixed plate. The program discretized
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and solved a 9-parameter Mooney-Rivlin model over the dome while undergoing
unconfined deformation from a 500µm indenter that was modeled as a rigid surface.
4.2.9 FFT Analysis
To quantify the interactions between tight junctions and ATP-transporters, fastFourier transforms (FFT) were calculated for ZO-1 and ATP-A1 on the bottom and top of
the fluid-filled domes. FFT converts spatial coordinates into Fourier frequency data to
generate Gaussian curves to fit this data.
4.2.10 Statistical Analysis
The open-source statistics package, R, was used to perform all statistical
calculations. Data sets were tested for normality with Shapiro-Wilk tests prior to testing
for significance. One and two-way ANOVA tests followed by Tukey HSD post-hoc
comparisons were used to evaluate significant differences between multiple conditions.
All other two sample comparisons were made using Student’s t-tests. Each statistical test
used sample numbers greater than or equal to 3 unless otherwise noted and p < 0.05 was
considered significant. All error bars indicate standard deviation of the mean.
4.3 Results
4.3.1 Characterization of iPSC Multicellular Domes
Confocal microscopy was used to characterize the geometry of hemispherical domes
created by induced
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pluripotent stem cells following addition of retinoic acid. Image stacks were taken
throughout the z-direction to visualize cross-sections for the entire height of the domes,
using phalloidin and DAPI to visualize F-actin and nuclei, respectively (Fig. 20A). Cells
were observed on the bottom of the dome as well as on sides and top, yielding a fully
encapsulated liquid droplet. The morphology of the cells at the top and bottom of the
dome varied substantially, with cells on the top of the dome appearing much smaller in
area, as shown in Figures 1B-D. The domes also featured clear localization of zonulaoccludens-1 (ZO-1) to the cell-cell junctions throughout the structure (Fig. 20E), and
confocal stacks revealed a columnar morphology characteristic of epithelial
cells and localization of the ZO-1 to the apical surface of the cell layer (Fig. 20F). In
order to characterize the permeability of the cell-cell junctions formed within the dome,
4-kDa dextran was added to the culture medium so that its rate of diffusion could be
quantified from time lapse microscopy (Fig. 20G-H). To provide further evidence that the
cells were not endothelial in nature, we added RhoA activator to the medium to stimulate
binding of the small GTPase to GTP, given our previous finding in blood-brain barrier
integrity endothelialized vessels that RhoA activation causes breakdown of tight
junctions. Although the permeability was increased in RhoA activated samples, there was
no significant difference compared to controls (Fig. 20I). Domes were probed with an
antibody for ATP1-A1, a sodium/potassium transporter commonly expressed by
epithelial phenotypes, and the expression was analyzed on the top and bottom surfaces of
the dome. The presence of aquaporin 2 was also interrogated since previous reports had
initially suggested that the method of differentiating blood-brain barrier endothelial cells
from iPS cells produced a neuroepithelial phenotype, but the expression did not appear
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robust. Immunofluorescence using markers for aquaporin 2 and TTR, both associated
with the neuroepithelium, did not exhibit a strong signal in these cells. In contrast, there
was robust expression of ATP1-A1 in both the bottom and top surfaces (Fig. 21A, B).
The localization of the transporter appeared to be somewhat different between the
surfaces though: on the bottom surface there appeared to be more localization with the
cell-cell junction whereas the transporter had no correlation to the junctions of the top
surface. To determine the co-localization of transporters and tight junctions, fast-Fourier
transforms (FFT) were performed for the alignment of F-actin, ZO-1 and ATP-A1 to
convert spatial coordinates into frequency data and distribution curves were used to fit
the data. Figure 2C shows similar distributions between ATP-A1 and ZO-1 and F-actin at
the bottom compared to the top of the domes (Fig. 21D). This data is consistent with a
previous study regarding the co-localization of sodium/potassium transporters to the
junctions, indicating that the cells at the top of the domes are more active compared to the
bottom[143]. Given the morphological differences between the top and bottom portions
of the dome, both the cell area and cell circularity were quantified. Cells on the top
surface of the dome exhibited significantly lower spread area and increased circularity
(Fig. 21E, F), which is consistent with previous studies identifying super elasticity in
cells on the surface of dome structures[120].
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Figure 1. Representative dome morphology of iPSC-derived epithelial cells. A) Confocal stack showing the hemispherical geometry and slices at the
mis-section (B), bottom (C), and top (D). E) ZO-1 staining of a dome showing cell–cell junction localization. F) Side view of a dome showing ZO-1
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Figure 21. Differences in Cell Morphology and Protein Expression. (F-actin in (i), ZO-1
in (ii), and ATP-A1 in (iii)) between the bottom (A) and top (B) of the domes. FFT
analysis showing alignment of ATP-A1 to F-actin and ZO-1 in the bottom layer (C)
compared to the top layer (D). E) Measurement of cell circularity, and F) cell area
between bottom and top layers.
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4.3.2 Altering the RhoA-ROCK Signaling Axis During Dome Microindentation
A micro-tensiometer measured the force-displacement relationship of the domes
deformation and observed an exponential decay in force once indentation was halted.
Figure 23A provides a schematic of the two phases measured by the micro-tensiometer,
denoted as indentation and relaxation. A representative force trace as a function of time is
also shown, indicating the two distinct phases. Assuming the dome is incompressible,
deviation from a hemispherical shape increases the surface area and exerts a tensile force
during deformation. In contrast to a previous study using small, fluid-filled cysts that
found water transport to be a contributing factor to the mechanical response[135], the
deformation by the micro-tensiometer of 5-10 µm is small compared to the radius of the
domes. Nevertheless, studies were conducted to verify incompressibility and determine
whether water was expelled from the dome during indentation and relaxation.
Supplemental Figure 2 shows that compression of the domes in medium containing 4kDa dextran indicated no convection across the dome surface, as indicated by measuring
the fluorescence intensity in the medium surrounding the dome. A positive control for
these experiments involved rupturing the dome with the tip of a 30-gauge needle and
observing transport of the encapsulated fluid into the dextran-containing medium. Having
verified that indentation did not induce water transport across the dome surface, we
investigated the role of the RhoA-ROCK signaling axis during indentation and relaxation.
Figure 3B shows a schematic of the potential role of RhoA-mediated signaling in
activating cell contractility and altering dome mechanics during indentation and
relaxation. A Hertz contact equation for a rigid cylindrical indenter and a spherical halfspace characterized the indentation phase. A representative fit of the indentation data is
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shown in Figure 23C. The Hertz model cannot clarify the stiffness of the cell monolayer
itself, doing so requires a shell model as described in previous studies[144], but it
sufficiently describes the bulk mechanics of the cellular domes. As Figure 3D indicates,
all conditions exhibited a similar trend between effective stiffness and radius, indicating
that radius is the primary determinant of the dome’s resistance to the applied mechanical
force, similar to the Laplace-Young equation that states the pressure difference across a
hemispherical membrane is inversely proportional to the radius. The indentation data
indicates an approximately square root dependence on force consistent with previous
studies of hemispherical indentation[145]. The relaxation data measured by the
tensiometer after indenting the domes was significantly different between the testing
conditions. Figure 3E shows that y27632 treatment significantly decreased the relaxation
factor ( ), while RhoA activation significantly increased this parameter and caused the
domes to relax at a faster rate. There appeared to be no dependence of dome radius on the
relaxation factor for each of the three conditions. Therefore, although the effects of RhoA
activation and ROCK inhibition were not observable during indentation, modulation of
this signaling axis caused a significant difference during the relaxation phase of the
micro-tensiometer measurement.
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Figure 23. Mechanical Interrogation of Fluid Filled Domes. A) Representative
indentation (Shaded red) and relaxation (shaded blue) profile produced by the
tensiometer and a schematic of the two measurement phases. B) Schematic of the role of
RhoA-ROCK signaling and modulation with RhoA activator and y27632. B) Fitting
Hertz contact equation to the experimental indentation data. C) Effective elastic moduli
of domes calculated from the fitting for a range of radii and the three testing conditions:
control, y27632-treated, and RhoA Activator-treated. D) Relaxation factor for control,
y27632-treated, and RhoA Activator-treated conditions.

4.3.3 Computational Modeling of Dome Indentation
A computational model was devised to verify that the effect of ROCK inhibition
on monolayer mechanics does not alter the bulk mechanics of the fluid-filled domes.
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Previous studies have characterized the stress-train behavior of epithelial sheets with and
without y-27632 treatment[1], and this data was used to inform the constitutive equation
for monolayer mechanics in the finite element model contact model. Specifically, a
Mooney-Rivlin model was fit to the published data as shown in Figure 24A. This process
was repeated for cells treated with y27632 (Fig. 24B) to determine the values of the
constants in the Mooney-Rivlin constitutive equation. An axisymmetric finite element
model incorporating contact with a rigid indenter simulated the force required to indent
the circular dome. The von Mises stress distribution on the surface of the dome is shown
in Figures 24C and 24D for control and y27632-treated cells. The total displacement of
the dome is shown in Figures 24E and 24F, again for control and y27632-treated cells
respectively. The force-displacement predictions of the COMSOL model were fit to the
Hertz contact equation for a rigid, cylindrical indenter and a hemispherical, elastic body
used for the experimental data. Figure 4G shows that the COMSOL data fitted with the
Hertz contact model for both control and y27632-treated cells in a 150-µm radius dome
indicates that ROCK inhibition does not cause a substantial difference in dome
indentation. Effective elastic moduli generated by fitting the computational data for
domes of 100, 150, and 200-µm domes were plotted with the 95% confidence intervals
generated from both the control (green) and y27-treated (purple) experimental data in
Figure 24H. This data shows that the finite element model predicted stiffness within the
95% confidence intervals for both the control and y27-treated conditions, and therefore
supports the observation that modulation of the RhoA-ROCK signaling axis does not
alter the indentation behavior of the domes. Moreover, the agreement between predicted
and measured effective stiffness values validates the hyperelastic constitutive equation
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derived from earlier measurements of cell monolayer mechanics, demonstrating that
dome indentation can evaluate the tensile properties of multicellular structures.

76

Figure 24. Fit of Mooney-Rivlin Model to Stress-Strain Data of a Cell Monolayer from
Previously Published Data[1]For Both Control (a) and Y27632-Treated (B) Cells. CD) Finite element model showing stress distribution in the membrane during
deformation for control and y27632 treatment. E-F) Total displacement of the dome
for control and y27632 treatment. G) Fitting the Hertz contact equation to the forcedisplacement behavior predicted by the computational model. H) Plotting the
predicted effective elastic moduli against the 95% confidence intervals generated by
control and y27632 experimental data.
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4.4 Discussion
The results establish microindentation of cellular domes as a new approach to
interrogate the mechanical properties of cell monolayers and to assess the contribution of
RhoA-ROCK signaling to multicellular mechanics. The micro-tensiometer experiments
involve both an indentation phase as the probe translates downwards and a relaxation
phase while the probe is held stationary. The domes, regardless of ROCK inhibition or
RhoA activation, exhibit force-displacement behavior during indentation that is dictated
by the radius of the dome. This behavior is representative of the Young-Laplace equation
relating the pressure difference to the wall tension and radius of a spherical geometry:
decreasing radii increases pressure differences for a given wall tension. The square root
dependence of the effective stiffness calculated from the Hertz contact equation is also
consistent with previously published studies on the compression of spherical shells[145].
The results suggest that the effect of modulating the RhoA-ROCK signaling axis on the
effective stiffness is negligible compared to the influence of the dome radius in the
topologies evaluated in this study. The finite element model supports this finding, since
hyperelastic constitutive equations derived from previous studies interrogating the tensile
properties of epithelial (MDCK-II) cell sheets suspended between pillars with and
without ROCK inhibition[1] predict effective stiffness values that were within a 95%
confidence interval of the experimental measurements. Therefore, the indentation results
indicate that the mechanical properties of epithelial cell sheets are conserved across
different phenotypes, species, and measurement configurations, since the iPSC-derived
epithelial cells used here display a unique phenotype most similar to human colon
epithelial cells.
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In contrast to the indentation phase, ROCK inhibition and RhoA activation both
exert a significant effect on the relaxation dynamics of the domes, regardless of radius.
After indentation, the tensiometer measures an exponential decay in the force as the
position of the probe is held constant. The dynamics of this decay are altered by both
y27632 and RhoA activator treatment, suggesting that forces exerted at cell-cell junctions
by actomyosin contractility mediate the decay measured by the tensiometer. RhoA
activation significantly increases the rate at which the cells reach a steady state force,
while y27632 decreases this rate, increasing the time required for the cells to reach steady
state. Previous studies of cell monolayer stress relaxation have produced similar findings:
ROCK inhibition through y27632 results in decreased rates of relaxation of monolayers
suspended between a fixed rod and a force transducer[146]. These studies also suggest
that actomyosin pre-tension is a substantial determinant of the relaxation behavior of
multicellular structures [147]. Here, our results establish dome indentation as a new
approach to characterize the role of the RhoA-ROCK signaling axis on the relaxation
behavior of cell monolayers.
Although the studies here focus on the effects of actomyosin tension, future
studies using dome indentation can interrogate whether other downstream targets of
RhoA and ROCK signaling contribute to the dynamic relaxation behavior of cell
monolayers under tension. The RhoA-ROCK signaling axis has several downstream
targets beyond its role in actomyosin contractility by activating myosin light chain kinase
and inhibiting myosin light chain phosphatase. For example, ROCK can phosphorylate
vimentin, an intermediate filament with several roles in dictating cellular mechanics:
bolstering mechanical resistance to deformation and subsequently protecting the nucleus
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from damage[148, 149]. ROCK activation also inhibits actin stabilization through
activation of LIM kinase [150]. Furthermore, RhoA activation can link F-actin to spectrin
at the cell membrane by phosphorylating adducin[151], and recent studies have shown
that spectrins also co-localize with junctional proteins[25, 43]. These effects of RhoA and
ROCK activation on the cytoskeleton, beyond actomyosin contractility, can be studied
using dome indentation. Moreover, future studies can also interrogate contribution of
other cytoskeletal components independent of the RhoA-ROCK signaling axis. For
example, the role of microtubule polymerization during relaxation can be evaluated by
using nocodazole treatment.
However, one potential caveat of iPSC-derived cells to clarify the role of RhoAROCK signaling and cytoskeletal dynamics on monolayer mechanics is that the cells are
differentiated using a protocol intended to produce blood-brain barrier-forming
endothelial cells[141]. As recent transcriptomic studies have demonstrated, these cells are
not endothelial in nature[139]. The characteristics of the blood-brain barrier observed in
these cells, e.g., high electrical resistance values, ZO-1 localization to cell-cell junctions,
and low permeability to low molecular weight dextran are due to the epithelial phenotype
created by the differentiation protocol. The formation of domes described in this study
and the use of a hyperelastic constitutive equation derived from MDCK data provide
further evidence of the epithelial properties of cells differentiated using this protocol.
Nonetheless, future studies using the dome indentation approach should validate the
relaxation dynamics using a more established epithelial cell line than the iPSc-derived
cells used here

80

Chapter 5
Conclusions
The results presented here identify previously unreported components of signaling
mechanisms that mediate the effects of fluid shear stress and the SARS-CoV-2 spike
protein on the blood-brain barrier. Both stimuli share a common downstream target in
RhoA: fluid shear stress attenuates RhoA activation compared to static controls, but
exposure to the S1 peptide of the spike protein increases its activity in the presence of
flow. The results also suggest that a requisite level of shear stress is needed to activate
these mechanisms, given that levels of shear stress less than 0.7 dyn/cm2 are unable to
significantly increase barrier formation and maintenance during perfusion. Perfusion
experiments reveal that adducin-γ localizes to tight junctions in response to fluid shear
stress and that CD44 acts a mechanosensor to shear stress in the presence of HMW-HA.
In addition to endothelialized microvessels, the role of RhoA is also established by
microindentation of cellular domes that highlight the contribution of RhoA-ROCK
signaling to multicellular mechanics. The domes, regardless of ROCK inhibition or RhoA
activation, exhibit force-displacement behavior during indentation that is dictated by the
radius of the dome. Additionally, the indentation results indicate that the mechanical
properties of epithelial cell sheets are conserved across different phenotypes, species, and
measurement configurations, since the iPSC-derived epithelial cells used here display a
unique phenotype[139].
These results have several implications for the understanding of blood-brain
barrier mechanotransduction and how these pathways can be modified by pathologies like
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COVID-19. Several recent reports have described increased incidences of neurological
pathologies in patients suffering from severe cases of COVID-19 [30, 152], suggesting that
infection may be associated blood-brain barrier breakdown in these patients. The results of
this study suggest that the use of inhibitors of the Rho/ROCK pathway may serve as
potential therapeutics to treat COVID-19 patients. Recently, inhibitors of this pathway have
been explored in the clinical setting: y-27632, a ROCK inhibitor, attenuated the decrease
in ACE2 expression in an acute pulmonary embolism rat model[114]. However, the role
of ACE2 expression on the pathogenesis of COVID-19 remains unclear, given that the
receptor is simultaneously the primary binding target of the virus and also known to
attenuate adverse aspects of the renin-angiotensin system by converting angiotensin II to
angiotensin fragment 1-7. Here, the results indicate that shear stress reduces ACE2
expression compared to static controls, suggesting that vessels with reduced shear stress
exposure may be more susceptible to infection due to elevated ACE2 expression. However,
future studies will be conducted in the presence of physiological levels of angiotensin II to
determine how the interplay between shear stress, spike protein, and ACE2 expression
contributes to barrier homeostasis.
5.1 Future Work
Overall, the work presented in this dissertation identifies specific components of
signaling pathways downstream of fluid shear stress and the SARS-CoV-2 spike protein
that alter the blood-brain barrier. However, future work is needed to better establish the
interaction between these elements and between other mechanosensitive pathways. For
instance, fundamental questions remain why is CD44 localization to the apical and basal
membrane necessary for flow mechanotransduction, and how exactly does shear stress
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activate the receptor. Moreover, intermediate steps between CD44 activation and binding
of RhoA and Rac1 to GTP need to be identified to fully understand these signaling
pathways. Similarly, although the small GTPases have direct effects on the cell
cytoskeleton, they likely also alter gene expression through effects on transcription factors.
ROCK activation is associated with YAP translocation, which may be associated with
changes to CD44 and adducin expression, though experiments like RNA sequencing and
specifically CHiP sequencing are needed to confirm this hypothesis.
In addition to mechanistic studies, future work should also involve translating
these findings to more clinically relevant applications. Previous studies have already
reported improved clinical outcomes in stroke patient populations treated with fasudil, a
ROCK inhibitor[116]. However, Rac1 activation can also be induced therapeutically, and
may also mitigate barrier disruption during the “no-reflow” period following ischemic
stroke. Moreover, genetic screening of patients can provide insight into whether
mutations in the adducin gene correlate to poor outcomes in pathologies associated with
barrier disruption like stroke, Alzheimer’s disease, and even post-operative delirium. The
results presented in this dissertation will hopefully serve as a foundation for future
translational studies that can lessen the burden of patients suffering from neurological
disease.
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